###begin article-title 0
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in Vivo</italic>
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">S&#8414;</xref>
Inactive and Active States of the Interferon-inducible Resistance GTPase, Irga6, in Vivo*Sâƒž
###end article-title 0
###begin p 1
Present address: Institute of Clinical Pharmacology PAREXEL International GmbH, 14050 Berlin, Germany.
###end p 1
###begin p 2
###xml 184 205 184 205 <email xmlns:xlink="http://www.w3.org/1999/xlink">j.howard@uni-koeln.de</email>
 To whom correspondence should be addressed: Institute for Genetics, University of Cologne, Zulpicher Str. 47, 50674 Cologne, Germany. Tel.: 49-2214704864; Fax: 49-2214706749; E-mail: j.howard@uni-koeln.de. 
###end p 2
###begin p 3
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 3
###begin p 4
 applies to Author Choice Articles
###end p 4
###begin p 5
###xml 133 150 133 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma gondii</italic>
###xml 189 198 189 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 1045 1052 1045 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 133 150 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 189 198 <span type="species:ncbi:5811">T. gondii</span>
Irga6, a myristoylated, interferon-inducible member of the immunity-related GTPase family, contributes to disease resistance against Toxoplasma gondii in mice. Accumulation of Irga6 on the T. gondii parasitophorous vacuole membrane is associated with vesiculation and ultimately disruption of the vacuolar membrane in a process that requires an intact GTP-binding domain. The role of the GTP-binding domain of Irga6 in pathogen resistance is, however, unclear. We provide evidence that Irga6 in interferon-induced, uninfected cells is predominantly in a GDP-bound state that is maintained by other interferon-induced proteins. However, Irga6 that accumulates on the parasitophorous vacuole membrane after Toxoplasma infection is in the GTP-bound form. We demonstrate that a monoclonal antibody, 10D7, specifically detects GTP-bound Irga6, and we show that the formation of the 10D7 epitope follows from a GTP-dependent conformational transition of the N terminus of Irga6, anticipating an important role of the myristoyl group on Irga6 function in vivo.
###end p 5
###begin p 6
###xml 28 59 28 59 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Deutsche Forschungsgemeinschaft</grant-sponsor>
###xml 67 74 67 74 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">SPP1110</grant-num>
###xml 76 82 76 82 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">SFB635</grant-num>
###xml 88 94 88 94 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">SFB670</grant-num>
###xml 106 127 106 127 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">University of Cologne</grant-sponsor>
###xml 270 283 270 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This study was supported by Deutsche Forschungsgemeinschaft Grants SPP1110, SFB635, and SFB670 and by the University of Cologne. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 6
###begin p 7
The on-line version of this article (available at ) contains supplemental Fig. 1.
###end p 7
###begin p 8
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 8
###begin p 9
###xml 1237 1244 1237 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1314 1318 <span type="species:ncbi:10090">mice</span>
The biological activity of GTPases depends on the control of the GTP binding and hydrolysis cycle. For several classes of GTPase, such as the Ras family of small GTPases, the G-proteins coupled to seven-transmembrane receptors, and the translation initiation and elongation factors, the molecular mechanisms by which the GTP cycle is controlled are known in considerable detail, and the biological contexts in which the activity cycles of the proteins function are well understood. All of these proteins function in cyclical processes in cells where the binding of GTP by a GTPase initiates a conformational change that drives a forward step in the cycle, whereas the hydrolysis of GTP to GDP terminates the forward activity and reverts the GTPase to its inactive ground state. There has been considerable recent interest in the function of several anomalous large GTPase families active in cell-autonomous immune resistance. However, no systematic study of the role of the GTP binding and hydrolysis cycle has been undertaken in order to define the functions of these proteins in biological processes associated with active pathogen resistance. In this paper, we have made some progress toward defining components of the activity cycle in vivo of Irga6, an interferon-inducible 47-kDa GTPase of the IRG family in mice.
###end p 9
###begin p 10
###xml 3 4 3 4 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">3</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 447 454 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 504 520 504 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 586 587 573 574 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 620 621 594 595 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 691 693 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 897 905 859 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 978 980 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 504 520 <span type="species:ncbi:562">Escherichia coli</span>
IRG3 proteins are 47-kDa, interferon-inducible GTPases intimately involved in disease resistance against intracellular parasites in mice (1-12). Some biochemical parameters and the crystal structure of one member of the family, Irga6 (formerly IIGP1), have been determined (13). Irga6 possesses a Ras-like GTP-binding domain slung between two helical modules of unknown function. The N terminus carries a myristoylation signal (14) that is active in vivo (15). The nonmyristoylated protein purified from Escherichia coli has affinities in the micromolar range for GDP (approximately1 mum) and for GTP (approximately15 mum) and a low basal turnover rate from GTP to GDP of less than 0.1/min (16). Like many anomalous large GTPases, Irga6 shows cooperativity in specific turnover rate, with a maximum of approximately2.0/min. Cooperativity of Irga6 is also reflected in a tendency to form oligomers in vitro upon the addition of GTP that resolve upon hydrolysis of the substrate (16).
###end p 10
###begin p 11
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 274 276 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 343 360 331 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Toxoplasma gondii</italic>
###xml 446 447 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 449 450 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn6">4</xref>
###xml 599 600 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 602 603 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 996 997 984 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 343 360 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 440 443 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 469 472 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
The mode of action of IRG proteins in vivo is not well understood. After induction by interferons, IRG proteins including Irga6 are expressed at high levels in all cell types analyzed (17). Irga6 is approximately60% associated with the ER membrane and 40% freely cytosolic (15). Within a few minutes after infection by the protozoan parasite, Toxoplasma gondii, cytoplasmic Irga6 accumulates on the membrane of the parasitophorous vacuole (PVM) (8).4 Within 1-2 h, the PVM becomes vesiculated and ultimately disrupts, the parasite is exposed to the cytosol, and parasite replication is interrupted (6, 8). This succession of events is blocked if an interferon-stimulated infected cell is also expressing what we have previously described as a "functionally dominant negative" mutant of Irga6, Irga6-K82A, demonstrating that the cell-autonomous resistance process is dependent on the function of IRG proteins and suggesting the importance of GTP binding and hydrolysis in the biological function (8).
###end p 11
###begin p 12
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
Next to nothing is known about the role of the GTPase function of the IRG proteins in pathogen resistance. In an early experiment, evidence was presented that another IRG protein, Irgm3 (formerly IGTP), isolated by immunoprecipitation from interferon-stimulated cells, co-purified with bound GTP, and the authors suggested that, unusually for a GTPase, Irgm3 exists in interferon-induced cells constitutively in the GTP-bound state (18). It has so far not proved possible to effect a biochemical purification of Irgm3, so the kinetic parameters of this member of the IRG family, either as a guanylate binding protein or as a GTPase, are not known.
###end p 12
###begin p 13
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 293 302 293 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 283 286 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 293 302 <span type="species:ncbi:5811">T. gondii</span>
In this report, we have begun an analysis of the nucleotide-bound state of Irga6 in vivo in uninfected and infected cells. Our experiments strongly suggest that the resting state of Irga6 in the IFN-induced but uninfected cell is GDP-bound, whereas the Irga6 that accumulates on the PVM after T. gondii infection is in the GTP-bound state. Furthermore, our data suggest that the GDP-bound state of Irga6 in uninfected cells is actively maintained by a further interferon-inducible protein or proteins. We have shown elsewhere that this regulation is an active property of certain IRG proteins themselves (19). These results thus suggest that the resistance properties of Irga6 will prove to be properties of the GTP-bound, active state of the protein at the parasitophorous vacuole membrane. During the course of these studies, we demonstrated that a monoclonal antibody can detect the GTP-bound state of Irga6 with high specificity, and we show that the target epitope of this reagent is subject to conformational influences both from local structural elements and distantly from the nucleotide binding site.
###end p 13
###begin title 14
EXPERIMENTAL PROCEDURES
###end title 14
###begin p 15
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Expression Constructs</italic>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
Expression Constructs-The pGW1H-Irga6cTag1 construct was generated by amplification of the Irga6cTag1 sequence from pGEX-4T-2-Irga6cTag1 (former pGEX-4T-2-IIGP-m) (16) by using Irga6cTag1 forward (5'-cccccccccgtcgaccaccatgggtcagctgttctcttcacctaag-3') and reverse (5'-cccccccccgtcgactcagtcacgatgcggccgctcgagtcggcctag-3') primers and cloned into pGW1H vector (British Biotech) by SalI digestion. Mutations were introduced into the coding region of pGW1H-Irga6wt (15), pGW1H-Irga6cTag1, and pGEX-4T2-Irga6wt (16) according to the QuikChange site-directed mutagenesis kit (Stratagene) using the following forward and corresponding reverse primers: G2A, 5'-gagtcgaccaccatggctcagctgttctcttca-3'; Delta7-12, 5'-gggtcagctgttctctaataatgatttgccc-3'; Delta7-25, 5'-ccaccatgggtcagctgttctctaaatttaatacggg-3'; Delta20-25, 5'-gaataatgatttgccctccagcaaatttaatacgggaag-3'; F20A, 5'-gagaataatgatttgccctccagcgctactggttattttaag-3'; T21A, 5'-gaataatgatttgccctccagctttgctggttattttaag-3'; G22A, 5'-gccctccagctttactgcttattttaagaaatttaatacggg-3'; Y23A, 5'-gccctccagctttactggtgcttttaagaaatttaatacggg-3'; F24A, 5'-gccctccagctttactggttatgctaagaaatttaatacgggaag-3'; K25A, 5'-gccctccagctttactggttattttgcgaaatttaatacgggaag-3'; K82A, 5'-gggagacgggatcaggggcgtccagcttcatcaataccc-3'; S83N, 5'-ggagacgggatcagggaagaacagcttcatcaataccctg-3'; E106A, 5'-gctaaaactggggtggtggcggtaaccatggaaag-3'.
###end p 15
###begin p 16
###xml 0 37 0 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culture and Serological Reagents</italic>
###xml 508 517 504 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 564 565 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 607 616 603 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 879 880 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
###xml 193 197 <span type="species:ncbi:9913">calf</span>
###xml 293 297 <span type="species:ncbi:9913">calf</span>
###xml 508 529 <span type="species:ncbi:508771">T. gondii strain ME49</span>
###xml 607 621 <span type="species:ncbi:508771">T. gondii ME49</span>
###xml 755 760 <span type="species:ncbi:10090">mouse</span>
###xml 809 815 <span type="species:ncbi:9986">rabbit</span>
###xml 849 855 <span type="species:ncbi:9986">rabbit</span>
###xml 883 889 <span type="species:ncbi:9793">donkey</span>
###xml 895 900 <span type="species:ncbi:10090">mouse</span>
###xml 912 918 <span type="species:ncbi:9793">donkey</span>
###xml 924 930 <span type="species:ncbi:9986">rabbit</span>
###xml 970 974 <span type="species:ncbi:9925">goat</span>
###xml 980 985 <span type="species:ncbi:10090">mouse</span>
###xml 1014 1018 <span type="species:ncbi:9925">goat</span>
###xml 1024 1029 <span type="species:ncbi:10090">mouse</span>
###xml 1048 1059 <span type="species:ncbi:3704">horseradish</span>
###xml 1081 1085 <span type="species:ncbi:9925">goat</span>
###xml 1091 1096 <span type="species:ncbi:10090">mouse</span>
###xml 1221 1227 <span type="species:ncbi:9793">donkey</span>
###xml 1233 1239 <span type="species:ncbi:9986">rabbit</span>
###xml 1241 1247 <span type="species:ncbi:9793">donkey</span>
###xml 1253 1257 <span type="species:ncbi:9925">goat</span>
###xml 1263 1267 <span type="species:ncbi:9925">goat</span>
###xml 1273 1278 <span type="species:ncbi:10090">mouse</span>
###xml 1279 1290 <span type="species:ncbi:3704">horseradish</span>
Cell Culture and Serological Reagents-L929 (CCL-1) and gs3T3 (Invitrogen) mouse fibroblasts were cultured in IMDM or Dulbecco's modified Eagle's medium (both GIBCO) supplemented with 10% fetal calf serum (Biochrom). Hybridoma 10D7 and 10E7 cells were grown in IMDM, supplemented with 5% fetal calf serum. Cells were induced with 200 units/ml IFNgamma (Cell Concepts) for 24 h and transfected using FUGENE6 transfection reagent according to the manufacturer's protocol (Roche Applied Science). Propagation of T. gondii strain ME49 was done as described previously (8). gs3T3 cells were infected for 2 h with T. gondii ME49 strain at a multiplicity of infection of 8 24 h after IFNgamma stimulation. The following serological reagents were used: anti-Irga6 mouse monoclonal antibodies 10D7 and 10E7, anti-Irga6 rabbit polyclonal serum 165, anti-cTag1 rabbit polyclonal serum 2600 (8), donkey-anti-mouse Alexa 546, donkey anti-rabbit Alexa 488 (all from Molecular Probes), goat anti-mouse kappa light chain (Bethyl), goat anti-mouse kappa light chain horseradish peroxidase (Bethyl), goat anti-mouse kappa light chain-fluorescein isothiocyanate (Southern Biotech), 4',6-diamidino-2-phenylindole (Roche Applied Science), and donkey anti-rabbit, donkey anti-goat, and goat anti-mouse horseradish peroxidase (all from Amersham Biosciences).
###end p 16
###begin p 17
###xml 0 42 0 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Antibody Purification and Papain Digestion</italic>
###xml 211 212 211 212 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 242 243 242 243 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 282 283 282 283 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 406 407 406 407 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 438 439 438 439 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 449 450 449 450 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 695 696 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 696 699 690 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink">280</sub>
###xml 745 747 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
Antibody Purification and Papain Digestion-10D7 and 10E7 antibodies were purified from corresponding hybridoma supernatants over a Protein A-Sepharose column (Amersham Biosciences). Antibody was eluted with 50 mm sodium acetate, pH 3.5, 150 mm NaCl and pH-neutralized to 7.5 with 1 m Tris, pH 11. Buffer was exchanged five times subsequently by dilution of antibody-containing sample in papain buffer (75 mm phosphate buffer, pH 7.0, 75 mm NaCl, 2 mm EDTA) and concentrated in a centrifugal concentrator (Vivaspin20; Sartorius) with a 10 kDa cut-off filter at 2000 x g at 4 degreesC. The concentration of the antibodies was determined by using formula, concentration of antibody (mg/ml) = 0.8 x A280. Papain digestion was done according to Ref. 20. The papain-digested antibodies were further purified on a HiLoad 26/60 Superdex 75 preparation grade column (Amersham Biosciences) in papain buffer. Samples were incubated in SDS-PAGE sample buffer under nonreducing conditions and subjected to SDS-PAGE. Proteins were detected by colloidal Coomassie staining.
###end p 17
###begin p 18
###xml 0 32 0 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Treatment with Aluminum Fluoride</italic>
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 139 140 138 139 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 240 241 239 240 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 579 580 567 568 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 585 586 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 595 596 583 584 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 636 637 624 625 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 94 98 <span type="species:ncbi:9913">calf</span>
Treatment with Aluminum Fluoride-AlCl3 (Sigma) was added to 10 ml of IMDM containing no fetal calf serum to a final concentration of 300 mum and mixed by vigorous shaking. Subsequently, NaF (Sigma) was added to a final concentration of 10 mm and mixed, and the final solution was applied to confluent L929 cells previously induced with IFNgamma or transfected for 24 h. Cells were incubated in aluminum fluoride complex (AlFx) solution for 30 min at 37 degreesC and then washed with cold PBS and collected by scraping. Cell pellets were lysed in 0.1% Thesit/PBS containing 300 mum AlCl3 and 10 mm NaF in the presence or absence of 0.5 mm GTP for 1 h at 4 degreesC.
###end p 18
###begin p 19
###xml 0 42 0 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunoprecipitation and Immunofluorescence</italic>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 260 261 256 257 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 266 267 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 430 431 420 421 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 462 463 447 448 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 468 469 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 478 479 463 464 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 519 520 504 505 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 811 812 781 782 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 874 875 844 845 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1032 1034 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 644 649 <span type="species:ncbi:10090">mouse</span>
###xml 702 708 <span type="species:ncbi:9986">rabbit</span>
Immunoprecipitation and Immunofluorescence-Immunoprecipitation was modified from Ref. 21. 1 x 106 L929 fibroblasts/sample were induced with IFNgamma and/or transfected for 24 h (or left untreated) and harvested by scraping. Cells were lysed in 0.1% Thesit, 3 mm MgCl2, PBS, Complete Mini protease inhibitor mixture without EDTA (Roche Applied Science) for 1 h at 4 degreesC in the absence of nucleotide or in the presence of 0.5 mm GDP, GTP, GTPgammaS, or 300 mum AlCl3 and 10 mm NaF in the presence or absence of 0.5 mm GTP (all from Sigma). Protein A-Sepharosetrade mark CL-4B beads (Amersham Biosciences) were incubated with 10D7 monoclonal mouse anti-Irga6 antibody or 2600 (anti-cTag1) polyclonal rabbit serum for 1 h at 4 degreesC. Bound proteins were eluted by boiling for 10 min in elution buffer (100 mm Tris/HCl, pH 8.5, 0.5% SDS) with SDS-PAGE sample buffer (50 mm Tris/HCl, pH 6.1, 1% SDS, 5% glycerol, 0.0025% bromphenol blue (w/v), 0.7% beta-mercaptoethanol). Immunofluorescence was preformed as previously described (15).
###end p 19
###begin p 20
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 66 9 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10D7 antibody detects Irga6 at the PVM but not at the ER.</bold>
###xml 149 158 145 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 281 284 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 340 341 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 352 353 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 356 361 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 364 366 360 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PC</italic>
###xml 437 447 433 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowheads</italic>
###xml 9 571 9 567 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21"><bold>10D7 antibody detects Irga6 at the PVM but not at the ER.</bold> gs3T3 fibroblasts were induced with IFN&#947; for 24 h prior to 2-h infection with <italic>T. gondii</italic> ME49 strain with a multiplicity of infection of 8. Irga6 protein was labeled with rabbit anti-Irga6 polyclonal serum 165 (<italic>red</italic>) and with mouse monoclonal anti-Irga6 antibodies 10E7 (<italic>A</italic>) or 10D7 (<italic>B</italic>) (<italic>green</italic>). <italic>PC</italic>, phase-contrast images. Parasitophorous vacuoles are indicated by the <italic>arrowheads</italic>. 10D7 detected Irga6 on the PVM efficiently but the cytoplasmic, ER membrane-associated Irga6 at a barely detectable level.</p>
###xml 9 571 9 567 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21"><bold>10D7 antibody detects Irga6 at the PVM but not at the ER.</bold> gs3T3 fibroblasts were induced with IFN&#947; for 24 h prior to 2-h infection with <italic>T. gondii</italic> ME49 strain with a multiplicity of infection of 8. Irga6 protein was labeled with rabbit anti-Irga6 polyclonal serum 165 (<italic>red</italic>) and with mouse monoclonal anti-Irga6 antibodies 10E7 (<italic>A</italic>) or 10D7 (<italic>B</italic>) (<italic>green</italic>). <italic>PC</italic>, phase-contrast images. Parasitophorous vacuoles are indicated by the <italic>arrowheads</italic>. 10D7 detected Irga6 on the PVM efficiently but the cytoplasmic, ER membrane-associated Irga6 at a barely detectable level.</p></caption>
###xml 571 571 567 567 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330001"/>
###xml 0 571 0 567 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="21"><bold>10D7 antibody detects Irga6 at the PVM but not at the ER.</bold> gs3T3 fibroblasts were induced with IFN&#947; for 24 h prior to 2-h infection with <italic>T. gondii</italic> ME49 strain with a multiplicity of infection of 8. Irga6 protein was labeled with rabbit anti-Irga6 polyclonal serum 165 (<italic>red</italic>) and with mouse monoclonal anti-Irga6 antibodies 10E7 (<italic>A</italic>) or 10D7 (<italic>B</italic>) (<italic>green</italic>). <italic>PC</italic>, phase-contrast images. Parasitophorous vacuoles are indicated by the <italic>arrowheads</italic>. 10D7 detected Irga6 on the PVM efficiently but the cytoplasmic, ER membrane-associated Irga6 at a barely detectable level.</p></caption><graphic xlink:href="zbc0480856330001"/></fig>
###xml 44 47 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 149 163 <span type="species:ncbi:508771">T. gondii ME49</span>
###xml 241 247 <span type="species:ncbi:9986">rabbit</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
###xml 476 479 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
FIGURE 1.10D7 antibody detects Irga6 at the PVM but not at the ER. gs3T3 fibroblasts were induced with IFNgamma for 24 h prior to 2-h infection with T. gondii ME49 strain with a multiplicity of infection of 8. Irga6 protein was labeled with rabbit anti-Irga6 polyclonal serum 165 (red) and with mouse monoclonal anti-Irga6 antibodies 10E7 (A) or 10D7 (B) (green). PC, phase-contrast images. Parasitophorous vacuoles are indicated by the arrowheads. 10D7 detected Irga6 on the PVM efficiently but the cytoplasmic, ER membrane-associated Irga6 at a barely detectable level.
###end p 20
###begin p 21
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10D7 antibody detects Irga6 at the PVM but not at the ER.</bold>
###xml 140 149 136 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 272 275 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 331 332 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 343 344 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 347 352 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 355 357 351 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PC</italic>
###xml 428 438 424 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowheads</italic>
###xml 35 38 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 140 154 <span type="species:ncbi:508771">T. gondii ME49</span>
###xml 232 238 <span type="species:ncbi:9986">rabbit</span>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
###xml 467 470 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
10D7 antibody detects Irga6 at the PVM but not at the ER. gs3T3 fibroblasts were induced with IFNgamma for 24 h prior to 2-h infection with T. gondii ME49 strain with a multiplicity of infection of 8. Irga6 protein was labeled with rabbit anti-Irga6 polyclonal serum 165 (red) and with mouse monoclonal anti-Irga6 antibodies 10E7 (A) or 10D7 (B) (green). PC, phase-contrast images. Parasitophorous vacuoles are indicated by the arrowheads. 10D7 detected Irga6 on the PVM efficiently but the cytoplasmic, ER membrane-associated Irga6 at a barely detectable level.
###end p 21
###begin p 22
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Colloidal Coomassie Staining</italic>
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Colloidal Coomassie Staining-Gels were washed 30 min with H2O and subsequently placed in incubation solution (17% ammonium sulfate (w/v), 20% MeOH, 2% phosphoric acid). After a 60-min incubation, solid Coomassie Brilliant Blue G-250 (Serva) was added to the solution to a concentration of 330 mg/500 ml and incubated 1-2 days. The gels were destained by incubation in 20% MeOH for 1 min and stored in 5% acetic acid. All was done at room temperature and while shaking.
###end p 22
###begin p 23
###xml 0 58 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Expression and Purification of Irga6 Proteins from E. coli</italic>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 168 169 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 169 172 163 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 215 216 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 270 271 264 265 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 287 288 278 279 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 360 361 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 407 408 386 387 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 639 640 618 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 809 810 782 783 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 843 844 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 1002 1003 969 970 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1120 1122 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 51 58 <span type="species:ncbi:562">E. coli</span>
###xml 114 121 <span type="species:ncbi:562">E. coli</span>
Expression and Purification of Irga6 Proteins from E. coli-pGEX-4T-2-Irga6 constructs were transformed into BL-21 E. coli strain. Cells were grown at 37 degreesC to an A600 of 0.8 when the expression of glutathione S-transferase-fused Irga6 proteins was induced by 0.1 mm isopropyl-beta-d-thiogalactoside at 18 degreesC overnight. Cells were harvested (5000 x g, 15 min, 4 degreesC); resuspended in PBS, 2 mm DTT, Complete Mini protease inhibitor mixture without EDTA (Roche Applied Science) and lysed using a microfluidizer (EmulsiFlex-C5; Avestin) at a pressure of 150 megapascals. The lysates were cleared by centrifugation at 50,000 x g for 60 min at 4 degreesC. The soluble fraction was purified on a glutathione-Sepharose affinity column (GSTrap FF 5 ml; Amersham Biosciences) equilibrated with PBS, 2 mm dithiothreitol. The glutathione S-transferase domain was cleaved off by overnight incubation with thrombin (20 units/ml; Serva) on the resin at 4 degreesC. Free Irga6 was eluted with PBS, 2 mm dithiothreitol, and the protein content in fractions was analyzed by SDS-PAGE and visualized by Coomassie staining (22). The protein-containing fractions were concentrated in a centrifugal concentrator (Vivaspin20; Sartorius). Aliquots were shock-frozen in liquid nitrogen and stored at -80 degreesC. The concentration of protein was determined by UV spectrophotometry at 280 nm.
###end p 23
###begin title 24
RESULTS
###end title 24
###begin p 25
###xml 0 114 0 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The Anti-Irga6 Monoclonal Antibody, 10D7, Recognizes a Distinct Conformation of Irga6 Present at the T. gondii PVM</italic>
###xml 245 247 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 270 279 266 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 329 330 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 618 620 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 693 699 681 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 791 800 779 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 812 818 800 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 820 830 808 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowheads</italic>
###xml 1565 1566 1553 1554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1571 1572 1559 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1557 1572 1545 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, <italic>A</italic> and <italic>B</italic></xref>
###xml 1810 1811 1798 1799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1804 1811 1792 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 2383 2392 2371 2380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 2660 2661 2644 2645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2654 2661 2638 2645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 3080 3087 3064 3071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 101 110 <span type="species:ncbi:5811">T. gondii</span>
###xml 111 114 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 270 279 <span type="species:ncbi:5811">T. gondii</span>
###xml 324 327 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
###xml 774 777 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 791 800 <span type="species:ncbi:5811">T. gondii</span>
###xml 1003 1006 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 1134 1137 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 2276 2279 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 2383 2392 <span type="species:ncbi:5811">T. gondii</span>
###xml 2393 2396 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 2494 2499 <span type="species:ncbi:10090">mouse</span>
###xml 2709 2712 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 2892 2895 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
The Anti-Irga6 Monoclonal Antibody, 10D7, Recognizes a Distinct Conformation of Irga6 Present at the T. gondii PVM-Irga6 is detected in a reticular pattern throughout IFNgamma-induced cells, most accurately co-localizing with the ER marker TAP (15). Upon infection with T. gondii, however, Irga6 is rapidly recruited to the PVM (8). In IFNgamma-induced mouse fibroblasts, we compared by indirect immunofluorescence the intracellular binding behavior of two IgG1 monoclonal antibodies raised against recombinant Irga6. Antibody 10E7 showed strong fine reticular staining typical of ER-localized IFNgamma-induced Irga6 (15), whereas cytoplasmic Irga6 was scarcely detectable with antibody 10D7 (Fig. 1). In contrast, 10D7 and 10E7 gave equally strong signals for Irga6 on the PVM of infecting T. gondii organisms (Fig. 1, arrowheads). We sought to distinguish between two alternative explanations for these results. Either 10D7 specifically recognized a determinant exposed only on the Irga6 bound to the PVM, or 10D7 was a low affinity antibody that could bind bivalently and hence stably to the concentrated, immobilized Irga6 at the PVM but not to the distributed Irga6 in the cytoplasmic pool. We therefore prepared monovalent Fab fragments of 10D7 by papain digestion. Since monovalent Fab fragments are unable to bind bivalently, they should bind equally, whether weakly or strongly, to distributed and aggregated targets. Following papain digestion, monovalent fragments were separated from residual bivalent material by size exclusion chromatography (Fig. 2, A and B, and supplemental Fig. 1). The binding activities of two fractions (B8 and B15, apparent molecular weights of 55,000 and 45,000, respectively) were compared by dilution in a Western blot against bacterially purified Irga6 protein (Fig. 2C). The titer of the later eluting fraction (B15) was higher than that of the earlier eluting fraction (B8), showing that the activity detected was not derived from trailing of residual bivalent material down the column. This result already indicated that monovalent 10D7 Fab fragment (fraction B15) has an affinity for Irga6 on a Western blot comparable with that of the native 10D7. It did not, however, prove that the monovalent affinity of 10D7 for Irga6 at the PVM is also high. We therefore examined the binding of Fab fragments from 10D7 to Irga6 accumulated on the T. gondii PVM in interferon-induced cells. The fragments were detected with a fluorescent conjugate of an anti-mouse kappa light chain second stage reagent and the intensities of 10D7 Fab and the bivalent native 10D7 antibody signals examined at constant exposure times. Fig. 2D shows that strong signals were detected at the PVM from both 10D7 Fab and intact 10D7, and the exposure times required for equivalent signal strength were essentially identical. Thus, 10D7 binds with high affinity to Irga6 at the PVM because Irga6 in this site adopts a conformation distinct from that present in the distributed cytoplasmic pool. Subsequent experiments were dedicated to showing that the two distinct in vivo conformations represent GTP-bound and GDP-bound states, respectively.
###end p 25
###begin p 26
###xml 0 40 0 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The Formation of Irga6 Oligomers in Vivo</italic>
###xml 99 107 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 730 731 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 724 731 720 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 825 831 821 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 1017 1024 1009 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 1029 1030 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 1099 1105 1087 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 1606 1614 1594 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1675 1677 1663 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 1749 1750 1737 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn7">5</xref>
###xml 2030 2037 2014 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2197 2203 2181 2187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 2314 2320 2298 2304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 2657 2658 2641 2642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2651 2658 2635 2642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 2797 2798 2781 2782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2791 2798 2775 2782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 3044 3045 3028 3029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 3047 3048 3031 3032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 3053 3054 3037 3038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 3038 3055 3022 3039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic>,(<italic>i</italic>) + (<italic>t</italic>)</xref>
###xml 3216 3217 3196 3197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 3219 3220 3199 3200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 3223 3224 3203 3204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 3210 3225 3190 3205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic>,(<italic>i</italic> + <italic>t</italic>)</xref>
###xml 3234 3235 3214 3215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 3228 3235 3208 3215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 3288 3295 3264 3271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 3300 3301 3276 3277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 3326 3327 3302 3303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 3332 3333 3308 3309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 3486 3487 3458 3459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 3490 3491 3462 3463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 3542 3543 3514 3515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 3548 3549 3520 3521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 3534 3549 3506 3521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A</italic> and <italic>C</italic></xref>
The Formation of Irga6 Oligomers in Vivo-Since purified Irga6 forms enzymatically active oligomers in vitro in the presence of GTP (16), we were interested to find out whether such oligomers could be detected in the uninfected, interferon-induced cell. To this end, we transfected IFNgamma-induced fibroblasts expressing wild-type Irga6 with an Irga6 construct modified at the C terminus with an 11-residue peptide tag, cTag1 (see "Experimental Procedures"), which causes a detectable size shift in SDS-PAGE. Twenty-four hours after transfection and interferon induction, Irga6cTag1 was immunoprecipitated from detergent lysates of the cells, and the product was resolved on SDS-PAGE and analyzed by Western blot for Irga6 (Fig. 3A). In the absence of added nucleotides, no co-precipitated wild-type Irga6 could be detected (lane 1); thus, there is no stable Irga6-Irga6 association in IFNgamma-induced cells. The addition of GDP or GTP to the lysate also failed to permit detectable coprecipitation of native Irga6 (lanes 2 and 3), but in the presence of the nonhydrolyzable GTP analog, GTPgammaS (lane 6), native Irga6 was strongly co-precipitated. These results suggested the possibility that Irga6cTag1 may indeed occur in cells in GTP-dependent oligomers with native Irga6 but that these rapidly hydrolyze GTP and dissociate again. However, the addition of nucleotides to the lysis risks the formation of artifactual postlysis oligomerization, and the results may not reflect the situation in the cell before lysis. It was shown earlier that the addition of AlFx and GTP to bacterially purified Irga6 in vitro resulted in the formation of irreversibly locked oligomers (16). The affinity of Irga6 for GDP is not altered by the presence of AlFx,5 and the addition of GDP and AlFx to Irga6 does not cause oligomerization. Thus, the AlFx binding site is accessible only during the catalytic step immediately after cleavage of the gamma-phosphate from GTP. AlFx is cell-permeant and therefore able to trap active Irga6 complexes in vivo. Although the addition of both AlFx and GTP during the immunoprecipitation procedure resulted in the co-precipitation of a significant amount of native Irga6 (lane 5), preincubation of the cells in AlFx before lysis failed to trap any mixed oligomers containing native Irga6 (lane 4). This result suggested, first, that no active, GTP-dependent oligomers are present in the uninfected, interferon-induced cells, and, second, that the complexes that were co-precipitated following the addition of nucleotides and AlFx to the lysate may have been formed postlysis. Proof that all of the mixed oligomers detected in Fig. 3A were indeed formed postlysis during the immunoprecipitation procedure itself was provided by the results of the experiment shown in Fig. 3C. Two separate cell populations were mixed at the time of lysis, one interferon-induced and the other transfected with Irga6cTag1. The mixed lysate was then immunoprecipitated for Irga6cTag1 in the presence of various nucleotides and AlFx (Fig. 3C,(i) + (t)) and compared with similar immunoprecipitates from the lysate of a single cell population that was both IFNgamma-induced and transfected with Irga6cTag1 (Fig. 3C,(i + t)). Fig. 3C shows that the addition of GTPgammaS or GTP + AlFx (lanes 5 and 6) to the mixed lysates ((i) + (t)) resulted in strong co-precipitation of the native Irga6, quantitatively equivalent to the co-precipitates found in transfected and IFNgamma-induced ((i + t)) cells. In summary, the results shown in Fig. 3, A and C, taken together provide strong evidence that Irga6 expressed in IFNgamma-induced cells is not present in the form of GTP-dependent oligomers of any size, including dimers.
###end p 26
###begin p 27
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 42 9 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10D7 is a high affinity antibody.</bold>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 615 616 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 621 622 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 900 901 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 906 907 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 910 911 894 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1322 1323 1305 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1464 1465 1447 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1544 1553 1523 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 1745 1751 1715 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lkappa</italic>
###xml 1859 1865 1829 1835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 1888 1897 1858 1867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 1908 1910 1878 1880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PC</italic>
###xml 9 1934 9 1904 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28"><bold>10D7 is a high affinity antibody.</bold> Papain-cleaved 10D7 antibody was separated on a Superdex 75 column. Fractions were subjected to SDS-PAGE on 7.5% gels under nonreducing conditions, and protein was detected by colloidal Coomassie staining (<italic>A</italic>) or Western blot (<italic>B</italic>) using goat anti-mouse &#954; light chain and donkey anti-goat horseradish peroxidase antibodies as primary and secondary stage detection reagents, respectively. The apparent molecular weight of native 10D7 IgG on SDS-PAGE was dependent on gel conditions. In relatively short runs in 7.5% gels, 10D7 ran in a complex band pattern below 130 kDa (<italic>A</italic> and <italic>B</italic>). However, the same material run longer in a 10% gel behaved rather normally, reaching an average position at or even above 150 kDa (see supplemental Fig. 1). Papain-cleaved fragments were shown to have an apparent molecular mass of &#8764;40 kDa in the 7.5% gel system (<italic>A</italic> and <italic>B</italic>). <italic>C</italic>, relative affinity of putative Fab fractions B8 and B15 of papain-cleaved 10D7 was estimated by binding to recombinant Irga6 fixed to the nitrocellulose membrane. 10 &#956;g/ml antibodies was considered as 1:1 and further dilutions were made, 1:2, 1:4, 1:8, 1:16, 1:32, and 1:64. A similar dilution series of uncleaved native 10D7 was made as positive controls. Detection of 10D7 and 10D7 fragments was done as in <italic>B</italic>. Monovalent 10D7 Fab fragment (fraction B15) has an affinity for denatured Irga6 on a Western blot comparable with that of the native 10D7. <italic>D</italic>, gs3T3 fibroblasts were induced with IFN&#947; 24 h followed by infection with <italic>T. gondii</italic> ME49 strain for 2 h. Irga6 was detected with 10 &#956;g/ml of 10D7 antibody (10D7) or 10D7 Fab; as secondary detection reagent, goat anti-mouse &#954; light chain-fluorescein isothiocyanate (&#945;<italic>Lkappa</italic>) was used. This secondary reagent detects papain-cleaved Fab and intact 10D7 with the same efficiency. The <italic>arrows</italic> indicate positions of <italic>T. gondii</italic> vacuoles. <italic>PC</italic>, phase-contrast images.</p>
###xml 9 1934 9 1904 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28"><bold>10D7 is a high affinity antibody.</bold> Papain-cleaved 10D7 antibody was separated on a Superdex 75 column. Fractions were subjected to SDS-PAGE on 7.5% gels under nonreducing conditions, and protein was detected by colloidal Coomassie staining (<italic>A</italic>) or Western blot (<italic>B</italic>) using goat anti-mouse &#954; light chain and donkey anti-goat horseradish peroxidase antibodies as primary and secondary stage detection reagents, respectively. The apparent molecular weight of native 10D7 IgG on SDS-PAGE was dependent on gel conditions. In relatively short runs in 7.5% gels, 10D7 ran in a complex band pattern below 130 kDa (<italic>A</italic> and <italic>B</italic>). However, the same material run longer in a 10% gel behaved rather normally, reaching an average position at or even above 150 kDa (see supplemental Fig. 1). Papain-cleaved fragments were shown to have an apparent molecular mass of &#8764;40 kDa in the 7.5% gel system (<italic>A</italic> and <italic>B</italic>). <italic>C</italic>, relative affinity of putative Fab fractions B8 and B15 of papain-cleaved 10D7 was estimated by binding to recombinant Irga6 fixed to the nitrocellulose membrane. 10 &#956;g/ml antibodies was considered as 1:1 and further dilutions were made, 1:2, 1:4, 1:8, 1:16, 1:32, and 1:64. A similar dilution series of uncleaved native 10D7 was made as positive controls. Detection of 10D7 and 10D7 fragments was done as in <italic>B</italic>. Monovalent 10D7 Fab fragment (fraction B15) has an affinity for denatured Irga6 on a Western blot comparable with that of the native 10D7. <italic>D</italic>, gs3T3 fibroblasts were induced with IFN&#947; 24 h followed by infection with <italic>T. gondii</italic> ME49 strain for 2 h. Irga6 was detected with 10 &#956;g/ml of 10D7 antibody (10D7) or 10D7 Fab; as secondary detection reagent, goat anti-mouse &#954; light chain-fluorescein isothiocyanate (&#945;<italic>Lkappa</italic>) was used. This secondary reagent detects papain-cleaved Fab and intact 10D7 with the same efficiency. The <italic>arrows</italic> indicate positions of <italic>T. gondii</italic> vacuoles. <italic>PC</italic>, phase-contrast images.</p></caption>
###xml 1934 1934 1904 1904 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330002"/>
###xml 0 1934 0 1904 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="28"><bold>10D7 is a high affinity antibody.</bold> Papain-cleaved 10D7 antibody was separated on a Superdex 75 column. Fractions were subjected to SDS-PAGE on 7.5% gels under nonreducing conditions, and protein was detected by colloidal Coomassie staining (<italic>A</italic>) or Western blot (<italic>B</italic>) using goat anti-mouse &#954; light chain and donkey anti-goat horseradish peroxidase antibodies as primary and secondary stage detection reagents, respectively. The apparent molecular weight of native 10D7 IgG on SDS-PAGE was dependent on gel conditions. In relatively short runs in 7.5% gels, 10D7 ran in a complex band pattern below 130 kDa (<italic>A</italic> and <italic>B</italic>). However, the same material run longer in a 10% gel behaved rather normally, reaching an average position at or even above 150 kDa (see supplemental Fig. 1). Papain-cleaved fragments were shown to have an apparent molecular mass of &#8764;40 kDa in the 7.5% gel system (<italic>A</italic> and <italic>B</italic>). <italic>C</italic>, relative affinity of putative Fab fractions B8 and B15 of papain-cleaved 10D7 was estimated by binding to recombinant Irga6 fixed to the nitrocellulose membrane. 10 &#956;g/ml antibodies was considered as 1:1 and further dilutions were made, 1:2, 1:4, 1:8, 1:16, 1:32, and 1:64. A similar dilution series of uncleaved native 10D7 was made as positive controls. Detection of 10D7 and 10D7 fragments was done as in <italic>B</italic>. Monovalent 10D7 Fab fragment (fraction B15) has an affinity for denatured Irga6 on a Western blot comparable with that of the native 10D7. <italic>D</italic>, gs3T3 fibroblasts were induced with IFN&#947; 24 h followed by infection with <italic>T. gondii</italic> ME49 strain for 2 h. Irga6 was detected with 10 &#956;g/ml of 10D7 antibody (10D7) or 10D7 Fab; as secondary detection reagent, goat anti-mouse &#954; light chain-fluorescein isothiocyanate (&#945;<italic>Lkappa</italic>) was used. This secondary reagent detects papain-cleaved Fab and intact 10D7 with the same efficiency. The <italic>arrows</italic> indicate positions of <italic>T. gondii</italic> vacuoles. <italic>PC</italic>, phase-contrast images.</p></caption><graphic xlink:href="zbc0480856330002"/></fig>
###xml 278 282 <span type="species:ncbi:9925">goat</span>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 316 322 <span type="species:ncbi:9793">donkey</span>
###xml 328 332 <span type="species:ncbi:9925">goat</span>
###xml 333 344 <span type="species:ncbi:3704">horseradish</span>
###xml 1544 1558 <span type="species:ncbi:508771">T. gondii ME49</span>
###xml 1678 1682 <span type="species:ncbi:9925">goat</span>
###xml 1688 1693 <span type="species:ncbi:10090">mouse</span>
###xml 1888 1897 <span type="species:ncbi:5811">T. gondii</span>
FIGURE 2.10D7 is a high affinity antibody. Papain-cleaved 10D7 antibody was separated on a Superdex 75 column. Fractions were subjected to SDS-PAGE on 7.5% gels under nonreducing conditions, and protein was detected by colloidal Coomassie staining (A) or Western blot (B) using goat anti-mouse kappa light chain and donkey anti-goat horseradish peroxidase antibodies as primary and secondary stage detection reagents, respectively. The apparent molecular weight of native 10D7 IgG on SDS-PAGE was dependent on gel conditions. In relatively short runs in 7.5% gels, 10D7 ran in a complex band pattern below 130 kDa (A and B). However, the same material run longer in a 10% gel behaved rather normally, reaching an average position at or even above 150 kDa (see supplemental Fig. 1). Papain-cleaved fragments were shown to have an apparent molecular mass of approximately40 kDa in the 7.5% gel system (A and B). C, relative affinity of putative Fab fractions B8 and B15 of papain-cleaved 10D7 was estimated by binding to recombinant Irga6 fixed to the nitrocellulose membrane. 10 mug/ml antibodies was considered as 1:1 and further dilutions were made, 1:2, 1:4, 1:8, 1:16, 1:32, and 1:64. A similar dilution series of uncleaved native 10D7 was made as positive controls. Detection of 10D7 and 10D7 fragments was done as in B. Monovalent 10D7 Fab fragment (fraction B15) has an affinity for denatured Irga6 on a Western blot comparable with that of the native 10D7. D, gs3T3 fibroblasts were induced with IFNgamma 24 h followed by infection with T. gondii ME49 strain for 2 h. Irga6 was detected with 10 mug/ml of 10D7 antibody (10D7) or 10D7 Fab; as secondary detection reagent, goat anti-mouse kappa light chain-fluorescein isothiocyanate (alphaLkappa) was used. This secondary reagent detects papain-cleaved Fab and intact 10D7 with the same efficiency. The arrows indicate positions of T. gondii vacuoles. PC, phase-contrast images.
###end p 27
###begin p 28
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10D7 is a high affinity antibody.</bold>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 606 607 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 612 613 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 891 892 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 897 898 881 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 901 902 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1313 1314 1296 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1455 1456 1438 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1535 1544 1514 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 1736 1742 1706 1712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lkappa</italic>
###xml 1850 1856 1820 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 1879 1888 1849 1858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 1899 1901 1869 1871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PC</italic>
###xml 269 273 <span type="species:ncbi:9925">goat</span>
###xml 279 284 <span type="species:ncbi:10090">mouse</span>
###xml 307 313 <span type="species:ncbi:9793">donkey</span>
###xml 319 323 <span type="species:ncbi:9925">goat</span>
###xml 324 335 <span type="species:ncbi:3704">horseradish</span>
###xml 1535 1549 <span type="species:ncbi:508771">T. gondii ME49</span>
###xml 1669 1673 <span type="species:ncbi:9925">goat</span>
###xml 1679 1684 <span type="species:ncbi:10090">mouse</span>
###xml 1879 1888 <span type="species:ncbi:5811">T. gondii</span>
10D7 is a high affinity antibody. Papain-cleaved 10D7 antibody was separated on a Superdex 75 column. Fractions were subjected to SDS-PAGE on 7.5% gels under nonreducing conditions, and protein was detected by colloidal Coomassie staining (A) or Western blot (B) using goat anti-mouse kappa light chain and donkey anti-goat horseradish peroxidase antibodies as primary and secondary stage detection reagents, respectively. The apparent molecular weight of native 10D7 IgG on SDS-PAGE was dependent on gel conditions. In relatively short runs in 7.5% gels, 10D7 ran in a complex band pattern below 130 kDa (A and B). However, the same material run longer in a 10% gel behaved rather normally, reaching an average position at or even above 150 kDa (see supplemental Fig. 1). Papain-cleaved fragments were shown to have an apparent molecular mass of approximately40 kDa in the 7.5% gel system (A and B). C, relative affinity of putative Fab fractions B8 and B15 of papain-cleaved 10D7 was estimated by binding to recombinant Irga6 fixed to the nitrocellulose membrane. 10 mug/ml antibodies was considered as 1:1 and further dilutions were made, 1:2, 1:4, 1:8, 1:16, 1:32, and 1:64. A similar dilution series of uncleaved native 10D7 was made as positive controls. Detection of 10D7 and 10D7 fragments was done as in B. Monovalent 10D7 Fab fragment (fraction B15) has an affinity for denatured Irga6 on a Western blot comparable with that of the native 10D7. D, gs3T3 fibroblasts were induced with IFNgamma 24 h followed by infection with T. gondii ME49 strain for 2 h. Irga6 was detected with 10 mug/ml of 10D7 antibody (10D7) or 10D7 Fab; as secondary detection reagent, goat anti-mouse kappa light chain-fluorescein isothiocyanate (alphaLkappa) was used. This secondary reagent detects papain-cleaved Fab and intact 10D7 with the same efficiency. The arrows indicate positions of T. gondii vacuoles. PC, phase-contrast images.
###end p 28
###begin p 29
###xml 124 126 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 128 130 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 352 354 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 570 571 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 564 571 552 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 628 629 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 622 629 606 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 670 676 654 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 1189 1196 1169 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
We have reported that Irga6 is substantially mislocalized when expressed in cells that have not been induced with IFNgamma (15, 19). The mislocalization is seen as small cytoplasmic aggregates instead of the smooth ER-related localization seen in IFNgamma-induced cells, and it can be prevented if the transfected cells are also induced with IFNgamma (19). The possibility that these aggregates represented GTP-dependent oligomers was tested directly by co-immunoprecipitation from uninduced cells transfected simultaneously with both native Irga6 and Irga6cTag1 (Fig. 3B). In this case, unlike in IFNgamma-induced cells (Fig. 3A), preincubation of the cells with AlFx (lane 4), before detergent lysis and in the absence of any exogenous nucleotide, allowed strong subsequent co-precipitation of wild-type Irga6 with Irga6cTag1. Since the AlFx binding site is inaccessible on GDP-bound Irga6, these results show that in the absence of other IFNgamma-induced proteins intracellular Irga6 exists at least partially in hydrolytically active, GTP-containing oligomers, which can be stabilized by AlFx in the living cell. These experiments showed that Irga6 can exist in two alternative states in vivo, namely monodispersed hydrolytically inert in the IFN-induced cell or assembled in GTP-dependent hydrolytically active oligomers in the transfected, uninduced cell.
###end p 29
###begin p 30
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 92 9 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In uninfected cells, Irga6 forms GTP-dependent oligomers only in the absence of IFN</bold>
###xml 209 210 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 322 323 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 353 354 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 357 358 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 377 378 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 383 384 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 460 461 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 631 637 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 723 736 707 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2, 3, 5</italic>
###xml 742 743 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 755 761 739 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 1007 1022 991 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">single asterisk</italic>
###xml 9 1131 9 1115 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31"><bold>In uninfected cells, Irga6 forms GTP-dependent oligomers only in the absence of IFN</bold>&#947;. L929 fibroblasts were simultaneously induced with IFN&#947; and transfected with Irga6cTag1 24 h before lysis (<italic>A</italic>), not induced with IFN&#947; but simultaneously transfected with both Irga6wt and Irga6cTag1 24 h before lysis (<italic>B</italic>), or either simultaneously ((<italic>i</italic> + <italic>t</italic>)) or separately ((<italic>i</italic>) + (<italic>t</italic>)) induced with IFN&#947; and transfected with Irga6cTag1 24 h before lysis (<italic>C</italic>). Irga6 was immunoprecipitated from lysates with rabbit anti-cTag1 serum. Cells were either preincubated with AlFx and subsequently lysed in the absence of nucleotides (<italic>lane 4</italic>) or without preincubation lysed in the presence of nucleotides with or without AlFx (<italic>lanes 2, 3, 5</italic>, and <italic>6</italic>). Cells in <italic>lane 1</italic> were immunoprecipitated without preincubation and without additives during the immunoprecipitation. Irga6 proteins in immunoprecipitates were detected with 10D7 antibody in a Western blot. A second band above wild-type Irga6cTag1 (marked with a <italic>single asterisk</italic>) is always found in Western blots of transfected Irga6; the nature of this presumed modification is unknown.</p>
###xml 9 1131 9 1115 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31"><bold>In uninfected cells, Irga6 forms GTP-dependent oligomers only in the absence of IFN</bold>&#947;. L929 fibroblasts were simultaneously induced with IFN&#947; and transfected with Irga6cTag1 24 h before lysis (<italic>A</italic>), not induced with IFN&#947; but simultaneously transfected with both Irga6wt and Irga6cTag1 24 h before lysis (<italic>B</italic>), or either simultaneously ((<italic>i</italic> + <italic>t</italic>)) or separately ((<italic>i</italic>) + (<italic>t</italic>)) induced with IFN&#947; and transfected with Irga6cTag1 24 h before lysis (<italic>C</italic>). Irga6 was immunoprecipitated from lysates with rabbit anti-cTag1 serum. Cells were either preincubated with AlFx and subsequently lysed in the absence of nucleotides (<italic>lane 4</italic>) or without preincubation lysed in the presence of nucleotides with or without AlFx (<italic>lanes 2, 3, 5</italic>, and <italic>6</italic>). Cells in <italic>lane 1</italic> were immunoprecipitated without preincubation and without additives during the immunoprecipitation. Irga6 proteins in immunoprecipitates were detected with 10D7 antibody in a Western blot. A second band above wild-type Irga6cTag1 (marked with a <italic>single asterisk</italic>) is always found in Western blots of transfected Irga6; the nature of this presumed modification is unknown.</p></caption>
###xml 1131 1131 1115 1115 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330003"/>
###xml 0 1131 0 1115 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="31"><bold>In uninfected cells, Irga6 forms GTP-dependent oligomers only in the absence of IFN</bold>&#947;. L929 fibroblasts were simultaneously induced with IFN&#947; and transfected with Irga6cTag1 24 h before lysis (<italic>A</italic>), not induced with IFN&#947; but simultaneously transfected with both Irga6wt and Irga6cTag1 24 h before lysis (<italic>B</italic>), or either simultaneously ((<italic>i</italic> + <italic>t</italic>)) or separately ((<italic>i</italic>) + (<italic>t</italic>)) induced with IFN&#947; and transfected with Irga6cTag1 24 h before lysis (<italic>C</italic>). Irga6 was immunoprecipitated from lysates with rabbit anti-cTag1 serum. Cells were either preincubated with AlFx and subsequently lysed in the absence of nucleotides (<italic>lane 4</italic>) or without preincubation lysed in the presence of nucleotides with or without AlFx (<italic>lanes 2, 3, 5</italic>, and <italic>6</italic>). Cells in <italic>lane 1</italic> were immunoprecipitated without preincubation and without additives during the immunoprecipitation. Irga6 proteins in immunoprecipitates were detected with 10D7 antibody in a Western blot. A second band above wild-type Irga6cTag1 (marked with a <italic>single asterisk</italic>) is always found in Western blots of transfected Irga6; the nature of this presumed modification is unknown.</p></caption><graphic xlink:href="zbc0480856330003"/></fig>
###xml 511 517 <span type="species:ncbi:9986">rabbit</span>
FIGURE 3.In uninfected cells, Irga6 forms GTP-dependent oligomers only in the absence of IFNgamma. L929 fibroblasts were simultaneously induced with IFNgamma and transfected with Irga6cTag1 24 h before lysis (A), not induced with IFNgamma but simultaneously transfected with both Irga6wt and Irga6cTag1 24 h before lysis (B), or either simultaneously ((i + t)) or separately ((i) + (t)) induced with IFNgamma and transfected with Irga6cTag1 24 h before lysis (C). Irga6 was immunoprecipitated from lysates with rabbit anti-cTag1 serum. Cells were either preincubated with AlFx and subsequently lysed in the absence of nucleotides (lane 4) or without preincubation lysed in the presence of nucleotides with or without AlFx (lanes 2, 3, 5, and 6). Cells in lane 1 were immunoprecipitated without preincubation and without additives during the immunoprecipitation. Irga6 proteins in immunoprecipitates were detected with 10D7 antibody in a Western blot. A second band above wild-type Irga6cTag1 (marked with a single asterisk) is always found in Western blots of transfected Irga6; the nature of this presumed modification is unknown.
###end p 30
###begin p 31
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In uninfected cells, Irga6 forms GTP-dependent oligomers only in the absence of IFN</bold>
###xml 200 201 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 313 314 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 344 345 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 348 349 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 368 369 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 374 375 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 451 452 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 622 628 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 714 727 698 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2, 3, 5</italic>
###xml 733 734 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 746 752 730 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 998 1013 982 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">single asterisk</italic>
###xml 502 508 <span type="species:ncbi:9986">rabbit</span>
In uninfected cells, Irga6 forms GTP-dependent oligomers only in the absence of IFNgamma. L929 fibroblasts were simultaneously induced with IFNgamma and transfected with Irga6cTag1 24 h before lysis (A), not induced with IFNgamma but simultaneously transfected with both Irga6wt and Irga6cTag1 24 h before lysis (B), or either simultaneously ((i + t)) or separately ((i) + (t)) induced with IFNgamma and transfected with Irga6cTag1 24 h before lysis (C). Irga6 was immunoprecipitated from lysates with rabbit anti-cTag1 serum. Cells were either preincubated with AlFx and subsequently lysed in the absence of nucleotides (lane 4) or without preincubation lysed in the presence of nucleotides with or without AlFx (lanes 2, 3, 5, and 6). Cells in lane 1 were immunoprecipitated without preincubation and without additives during the immunoprecipitation. Irga6 proteins in immunoprecipitates were detected with 10D7 antibody in a Western blot. A second band above wild-type Irga6cTag1 (marked with a single asterisk) is always found in Western blots of transfected Irga6; the nature of this presumed modification is unknown.
###end p 31
###begin p 32
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 92 9 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In noninduced cells, 10D7 detects aggregated Irga6 as efficiently as 10E7 antibody.</bold>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 284 286 284 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PC</italic>
###xml 9 310 9 310 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33"><bold>In noninduced cells, 10D7 detects aggregated Irga6 as efficiently as 10E7 antibody.</bold> Untreated gs3T3 fibroblasts were transfected with Irga6cTag1 and stained 24 h later with anti-cTag1 polyclonal serum (<italic>red</italic>) and with either 10E7 (<italic>A</italic>) or 10D7 (<italic>B</italic>) monoclonal antibodies (<italic>green</italic>). <italic>PC</italic>, phase-contrast images.</p>
###xml 9 310 9 310 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33"><bold>In noninduced cells, 10D7 detects aggregated Irga6 as efficiently as 10E7 antibody.</bold> Untreated gs3T3 fibroblasts were transfected with Irga6cTag1 and stained 24 h later with anti-cTag1 polyclonal serum (<italic>red</italic>) and with either 10E7 (<italic>A</italic>) or 10D7 (<italic>B</italic>) monoclonal antibodies (<italic>green</italic>). <italic>PC</italic>, phase-contrast images.</p></caption>
###xml 310 310 310 310 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330004"/>
###xml 0 310 0 310 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="33"><bold>In noninduced cells, 10D7 detects aggregated Irga6 as efficiently as 10E7 antibody.</bold> Untreated gs3T3 fibroblasts were transfected with Irga6cTag1 and stained 24 h later with anti-cTag1 polyclonal serum (<italic>red</italic>) and with either 10E7 (<italic>A</italic>) or 10D7 (<italic>B</italic>) monoclonal antibodies (<italic>green</italic>). <italic>PC</italic>, phase-contrast images.</p></caption><graphic xlink:href="zbc0480856330004"/></fig>
FIGURE 4.In noninduced cells, 10D7 detects aggregated Irga6 as efficiently as 10E7 antibody. Untreated gs3T3 fibroblasts were transfected with Irga6cTag1 and stained 24 h later with anti-cTag1 polyclonal serum (red) and with either 10E7 (A) or 10D7 (B) monoclonal antibodies (green). PC, phase-contrast images.
###end p 32
###begin p 33
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In noninduced cells, 10D7 detects aggregated Irga6 as efficiently as 10E7 antibody.</bold>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 241 242 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 275 277 275 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PC</italic>
In noninduced cells, 10D7 detects aggregated Irga6 as efficiently as 10E7 antibody. Untreated gs3T3 fibroblasts were transfected with Irga6cTag1 and stained 24 h later with anti-cTag1 polyclonal serum (red) and with either 10E7 (A) or 10D7 (B) monoclonal antibodies (green). PC, phase-contrast images.
###end p 33
###begin p 34
###xml 0 87 0 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The Conformation-sensitive Monoclonal Antibody, 10D7, Binds Irga6 in the GTP-bound Form</italic>
###xml 342 343 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4</xref>
###xml 349 350 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 348 350 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">5<italic>A</italic></xref>
###xml 486 492 482 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 540 541 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 534 541 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 968 969 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 962 969 954 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 971 976 963 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 1130 1132 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 698 701 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
The Conformation-sensitive Monoclonal Antibody, 10D7, Binds Irga6 in the GTP-bound Form-Since 10D7 binds very inefficiently to the monodispersed, cytoplasmic form of Irga6 expressed in IFNgamma-induced cells, it was of interest to find out whether the GTP-dependent Irga6 aggregates forming in transfected cells are recognized by 10D7. Figs. 4 and 5A show that 10D7 indeed binds as strongly to Irga6 aggregates in transfected cells as does the indiscriminate monoclonal antibody, 10E7 (Fig. 4), or the anti-cTag1-specific serum 2600 (Fig. 5A). Thus, the Irga6 conformation recognized by 10D7 is the GTP-dependent, hydrolytically active conformation, implying that Irga6 detected by 10D7 around the PVM in IFN-induced cells is itself in the GTP-bound state. The binding of 10D7 to transfected Irga6 was largely eliminated if transfected cells were simultaneously induced with IFNgamma, especially in cells expressing relatively little of the transfected protein (Fig. 5B, arrow). This result is consistent with other evidence that the presence of other IFNgamma-induced IRG proteins normally maintains Irga6 in the inactive state (19).
###end p 34
###begin p 35
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 584 585 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 587 589 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 747 749 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 952 953 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 946 953 938 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 969 970 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 963 970 955 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>D</italic></xref>
###xml 1094 1095 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1100 1101 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1086 1101 1074 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, <italic>E</italic> and <italic>F</italic></xref>
###xml 555 558 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
That 10D7 binds specifically to the GTP-bound, active state of Irga6 in vivo was further supported by the behavior of two nucleotide-binding site mutants of Irga6, the "functionally dominant negative" P-loop mutant, Irga6-K82A, and a further mutant that has lost affinity for both GDP and GTP, Irga6-S83N (19). We have shown elsewhere that transfected Irga6-K82A is functionally dominant negative in vivo, co-localizing in smaller or larger cytoplasmic aggregates with IFNgamma-induced wild-type Irga6 and inhibiting the accumulation of the latter on the PVM of infecting Toxoplasma (8, 19). We have further shown that, although behaving functionally as a dominant negative, Irga6-K82A binds GTP with wild-type affinity but fails to hydrolyze it (19). Consistent with the suggestion that 10D7 binds to the GTP-bound active form of Irga6, 10D7 also bound strongly to Irga6 in cells transfected with Irga6-K82A, whether they were IFNgamma-induced (Fig. 5C) or not (Fig. 5D), while binding weakly to cells transfected with Irga6-S83N, again independent of simultaneous IFNgamma induction (Fig. 5, E and F).
###end p 35
###begin p 36
###xml 0 63 0 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The Nature of the 10D7 Epitope and Conditions for Its Formation</italic>
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 135 142 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 592 599 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1020 1027 1020 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1092 1093 1092 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1086 1093 1086 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 1173 1175 1173 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">20</sup>
###xml 1183 1185 1183 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">23</sup>
###xml 1202 1204 1202 1204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">22</sup>
###xml 1209 1211 1209 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">24</sup>
###xml 1220 1222 1220 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">25</sup>
###xml 1263 1265 1263 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">21</sup>
###xml 1425 1426 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1419 1426 1419 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1486 1488 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1621 1623 1617 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">20</sup>
###xml 1628 1630 1624 1626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">23</sup>
###xml 1639 1641 1635 1637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">24</sup>
###xml 1736 1737 1732 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1730 1737 1726 1733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1920 1922 1916 1918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 1924 1926 1920 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 2037 2039 2033 2035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 2041 2043 2037 2039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 1020 1027 <span type="species:ncbi:562">E. coli</span>
The Nature of the 10D7 Epitope and Conditions for Its Formation-The 10D7 epitope of Irga6 was constitutively exposed on Western blots (Fig. 2C), suggesting that it is a linear epitope expressed by denatured protein. We further observed that the 10D7 epitope was also constitutively accessible in cells expressing the N-terminal 69 residues of Irga6 tagged at the C terminus with green fluorescent protein (data not shown). Thus, expression of the epitope is not dependent on the presence of the nucleotide binding or C-terminal domains. Deletion of residues 2-12 or 7-12 had no effect on the in vivo expression of the 10D7 epitope in these short constructs, whereas the epitope was eliminated by deletion of residues 7-25 (data not shown). By a combination of site-directed mutagenesis and short deletions of the full-length protein, it was possible to locate the epitope definitively between residues 20 and 25. Full-length Irga6 proteins carrying single replacements of residues 20-25 with alanines were purified from E. coli extracts and probed with 10E7 and 10D7 in a Western blot (Fig. 6A). Side chains essential for the formation of the 10D7 epitope were found at Phe20 and Tyr23; alanines at Gly22, Phe24, and Lys25 also weakened the signal. Alanine at Thr21 had no detectable effect, but a bulky substitution, T21I, also destroyed 10D7 binding (data not shown). Residues 20-25 of Irga6 make up most of Helix A (Fig. 6B), the first resolved helix of the Irga6 crystal structure (13). This alpha-helix is partly exposed to solvent in the structure and partly masked by contacts to Helix B, Helix C, and Helix F. Phe20, Tyr23, and Phe24 are buried in the interhelical space and not exposed on the solvent-accessible surface (Fig. 6C). In general, antibody epitopes on proteins are concentrated on loops and folds with a high degree of solvent exposure and are less common on regions of defined secondary structure (23, 24). Antibodies recognizing helical epitopes interact only with side chains on the exposed surface of the helix (25, 26). Taken together, therefore, the data suggest that the structure of the 10D7 epitope is not accurately reflected by Helix A of the crystal structure and that under conditions in which 10D7 binds to Irga6, Helix A is restructured into a solvent-exposed loop on which the linear epitope at residues 20-25 is accessible.
###end p 36
###begin p 37
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 101 9 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hydrolysis-deficient dominant-negative mutant of Irga6 forms aggregates independently of IFN</bold>
###xml 106 167 102 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink">-induced factors and constitutively exposes the 10D7 epitope.</bold>
###xml 183 184 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 189 190 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 210 211 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 216 217 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 273 274 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 279 280 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 356 360 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, C</italic>
###xml 366 367 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 411 415 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B, D</italic>
###xml 421 422 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 487 492 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 516 519 508 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 573 578 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 583 592 575 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 596 597 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 788 789 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 860 861 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 866 867 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 950 951 934 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 956 957 940 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 960 962 944 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PC</italic>
###xml 9 986 9 970 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><bold>Hydrolysis-deficient dominant-negative mutant of Irga6 forms aggregates independently of IFN</bold>&#947;<bold>-induced factors and constitutively exposes the 10D7 epitope.</bold> Irga6cTag1-wt (<italic>A</italic> and <italic>B</italic>), Irga6cTag1-K82A (<italic>C</italic> and <italic>D</italic>; functionally dominant negative), and Irga6cTag1-S83N (<italic>E</italic> and <italic>F</italic>) constructs were transfected into gs3T3 fibroblasts either in the absence (<italic>A, C</italic>, and <italic>E</italic>) or in the presence of IFN&#947; induction (<italic>B, D</italic>, and <italic>F</italic>). Transfected cells were stained 24 h later with 10D7 antibody (<italic>green</italic>) and anti-cTag1 serum (<italic>red</italic>). Images were taken with the same exposure time. The <italic>arrow</italic> and <italic>arrowhead</italic> in <italic>B</italic> indicate cells with lower and higher levels of transfected Irga6cTag1 protein, respectively. Treatment with IFN&#947; markedly attenuates the 10D7 signal on transfected wild-type Irga6cTag1 (<italic>B</italic>) but has no impact on the 10D7 signal of transfected Irga6cTag1-K82A (<italic>C</italic> and <italic>D</italic>). The 10D7 signal is weak on Irga6cTag1-S83N independently of IFN&#947; treatment (<italic>E</italic> and <italic>F</italic>). <italic>PC</italic>, phase-contrast images.</p>
###xml 9 986 9 970 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38"><bold>Hydrolysis-deficient dominant-negative mutant of Irga6 forms aggregates independently of IFN</bold>&#947;<bold>-induced factors and constitutively exposes the 10D7 epitope.</bold> Irga6cTag1-wt (<italic>A</italic> and <italic>B</italic>), Irga6cTag1-K82A (<italic>C</italic> and <italic>D</italic>; functionally dominant negative), and Irga6cTag1-S83N (<italic>E</italic> and <italic>F</italic>) constructs were transfected into gs3T3 fibroblasts either in the absence (<italic>A, C</italic>, and <italic>E</italic>) or in the presence of IFN&#947; induction (<italic>B, D</italic>, and <italic>F</italic>). Transfected cells were stained 24 h later with 10D7 antibody (<italic>green</italic>) and anti-cTag1 serum (<italic>red</italic>). Images were taken with the same exposure time. The <italic>arrow</italic> and <italic>arrowhead</italic> in <italic>B</italic> indicate cells with lower and higher levels of transfected Irga6cTag1 protein, respectively. Treatment with IFN&#947; markedly attenuates the 10D7 signal on transfected wild-type Irga6cTag1 (<italic>B</italic>) but has no impact on the 10D7 signal of transfected Irga6cTag1-K82A (<italic>C</italic> and <italic>D</italic>). The 10D7 signal is weak on Irga6cTag1-S83N independently of IFN&#947; treatment (<italic>E</italic> and <italic>F</italic>). <italic>PC</italic>, phase-contrast images.</p></caption>
###xml 986 986 970 970 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330005"/>
###xml 0 986 0 970 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="38"><bold>Hydrolysis-deficient dominant-negative mutant of Irga6 forms aggregates independently of IFN</bold>&#947;<bold>-induced factors and constitutively exposes the 10D7 epitope.</bold> Irga6cTag1-wt (<italic>A</italic> and <italic>B</italic>), Irga6cTag1-K82A (<italic>C</italic> and <italic>D</italic>; functionally dominant negative), and Irga6cTag1-S83N (<italic>E</italic> and <italic>F</italic>) constructs were transfected into gs3T3 fibroblasts either in the absence (<italic>A, C</italic>, and <italic>E</italic>) or in the presence of IFN&#947; induction (<italic>B, D</italic>, and <italic>F</italic>). Transfected cells were stained 24 h later with 10D7 antibody (<italic>green</italic>) and anti-cTag1 serum (<italic>red</italic>). Images were taken with the same exposure time. The <italic>arrow</italic> and <italic>arrowhead</italic> in <italic>B</italic> indicate cells with lower and higher levels of transfected Irga6cTag1 protein, respectively. Treatment with IFN&#947; markedly attenuates the 10D7 signal on transfected wild-type Irga6cTag1 (<italic>B</italic>) but has no impact on the 10D7 signal of transfected Irga6cTag1-K82A (<italic>C</italic> and <italic>D</italic>). The 10D7 signal is weak on Irga6cTag1-S83N independently of IFN&#947; treatment (<italic>E</italic> and <italic>F</italic>). <italic>PC</italic>, phase-contrast images.</p></caption><graphic xlink:href="zbc0480856330005"/></fig>
FIGURE 5.Hydrolysis-deficient dominant-negative mutant of Irga6 forms aggregates independently of IFNgamma-induced factors and constitutively exposes the 10D7 epitope. Irga6cTag1-wt (A and B), Irga6cTag1-K82A (C and D; functionally dominant negative), and Irga6cTag1-S83N (E and F) constructs were transfected into gs3T3 fibroblasts either in the absence (A, C, and E) or in the presence of IFNgamma induction (B, D, and F). Transfected cells were stained 24 h later with 10D7 antibody (green) and anti-cTag1 serum (red). Images were taken with the same exposure time. The arrow and arrowhead in B indicate cells with lower and higher levels of transfected Irga6cTag1 protein, respectively. Treatment with IFNgamma markedly attenuates the 10D7 signal on transfected wild-type Irga6cTag1 (B) but has no impact on the 10D7 signal of transfected Irga6cTag1-K82A (C and D). The 10D7 signal is weak on Irga6cTag1-S83N independently of IFNgamma treatment (E and F). PC, phase-contrast images.
###end p 37
###begin p 38
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hydrolysis-deficient dominant-negative mutant of Irga6 forms aggregates independently of IFN</bold>
###xml 97 158 93 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">-induced factors and constitutively exposes the 10D7 epitope.</bold>
###xml 174 175 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 180 181 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 201 202 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 207 208 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 264 265 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 270 271 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 347 351 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, C</italic>
###xml 357 358 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 402 406 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B, D</italic>
###xml 412 413 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 478 483 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 507 510 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 564 569 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 574 583 566 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 587 588 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 779 780 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 851 852 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 857 858 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 941 942 925 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 947 948 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 951 953 935 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PC</italic>
Hydrolysis-deficient dominant-negative mutant of Irga6 forms aggregates independently of IFNgamma-induced factors and constitutively exposes the 10D7 epitope. Irga6cTag1-wt (A and B), Irga6cTag1-K82A (C and D; functionally dominant negative), and Irga6cTag1-S83N (E and F) constructs were transfected into gs3T3 fibroblasts either in the absence (A, C, and E) or in the presence of IFNgamma induction (B, D, and F). Transfected cells were stained 24 h later with 10D7 antibody (green) and anti-cTag1 serum (red). Images were taken with the same exposure time. The arrow and arrowhead in B indicate cells with lower and higher levels of transfected Irga6cTag1 protein, respectively. Treatment with IFNgamma markedly attenuates the 10D7 signal on transfected wild-type Irga6cTag1 (B) but has no impact on the 10D7 signal of transfected Irga6cTag1-K82A (C and D). The 10D7 signal is weak on Irga6cTag1-S83N independently of IFNgamma treatment (E and F). PC, phase-contrast images.
###end p 38
###begin p 39
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 65 9 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10D7 epitope is located in the Helix A of Irga6 protein.</bold>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 404 405 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 443 445 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 523 526 511 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 650 652 638 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 676 688 664 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stick figure</italic>
###xml 693 705 681 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black sphere</italic>
###xml 721 737 709 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, enlarged view</italic>
###xml 770 771 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 786 791 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below</italic>
###xml 886 888 874 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">20</sup>
###xml 893 895 881 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">21</sup>
###xml 900 902 888 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink">23</sup>
###xml 907 909 895 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink">24</sup>
###xml 918 920 906 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">25</sup>
###xml 9 966 9 954 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><bold>10D7 epitope is located in the Helix A of Irga6 protein.</bold><italic>A</italic>, purified, nonmyristoylated recombinant Irga6wt, -&#916;7-12, -&#916;7-25, -&#916;20-25, -F20A, -T21A, -G22A, -Y23A, -F24A, and -K25A proteins were subjected to SDS-PAGE and detected in Western blot with 10E7 and 10D7 antibodies. 10D7 signals were quantified, and values for mutants are given as percentages relative to the Irga6wt signal; <italic>B</italic>, crystal structure of Irga6 monomer (<xref ref-type="bibr" rid="ref13">13</xref>), with Helix A, containing the 10D7 epitope, amino acids 20-25, indicated in <italic>red</italic>. The myristoyl group and the first 12 N-terminal amino acids have not yet been crystallographically resolved. GppNHp and Mg<sup>2+</sup> are shown as an atomic <italic>stick figure</italic> and <italic>black sphere</italic>, respectively; <italic>C, enlarged view</italic> of the structure shown in Fig. 6<italic>B</italic>, looking from <italic>below</italic> on the 4-helix bundle of which Helix A is a member. The orientations of the side chains of Phe<sup>20</sup>, Thr<sup>21</sup>, Tyr<sup>23</sup>, Phe<sup>24</sup>, and Lys<sup>25</sup> amino acids in the Irga6 structure are shown.</p>
###xml 9 966 9 954 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40"><bold>10D7 epitope is located in the Helix A of Irga6 protein.</bold><italic>A</italic>, purified, nonmyristoylated recombinant Irga6wt, -&#916;7-12, -&#916;7-25, -&#916;20-25, -F20A, -T21A, -G22A, -Y23A, -F24A, and -K25A proteins were subjected to SDS-PAGE and detected in Western blot with 10E7 and 10D7 antibodies. 10D7 signals were quantified, and values for mutants are given as percentages relative to the Irga6wt signal; <italic>B</italic>, crystal structure of Irga6 monomer (<xref ref-type="bibr" rid="ref13">13</xref>), with Helix A, containing the 10D7 epitope, amino acids 20-25, indicated in <italic>red</italic>. The myristoyl group and the first 12 N-terminal amino acids have not yet been crystallographically resolved. GppNHp and Mg<sup>2+</sup> are shown as an atomic <italic>stick figure</italic> and <italic>black sphere</italic>, respectively; <italic>C, enlarged view</italic> of the structure shown in Fig. 6<italic>B</italic>, looking from <italic>below</italic> on the 4-helix bundle of which Helix A is a member. The orientations of the side chains of Phe<sup>20</sup>, Thr<sup>21</sup>, Tyr<sup>23</sup>, Phe<sup>24</sup>, and Lys<sup>25</sup> amino acids in the Irga6 structure are shown.</p></caption>
###xml 966 966 954 954 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330006"/>
###xml 0 966 0 954 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="40"><bold>10D7 epitope is located in the Helix A of Irga6 protein.</bold><italic>A</italic>, purified, nonmyristoylated recombinant Irga6wt, -&#916;7-12, -&#916;7-25, -&#916;20-25, -F20A, -T21A, -G22A, -Y23A, -F24A, and -K25A proteins were subjected to SDS-PAGE and detected in Western blot with 10E7 and 10D7 antibodies. 10D7 signals were quantified, and values for mutants are given as percentages relative to the Irga6wt signal; <italic>B</italic>, crystal structure of Irga6 monomer (<xref ref-type="bibr" rid="ref13">13</xref>), with Helix A, containing the 10D7 epitope, amino acids 20-25, indicated in <italic>red</italic>. The myristoyl group and the first 12 N-terminal amino acids have not yet been crystallographically resolved. GppNHp and Mg<sup>2+</sup> are shown as an atomic <italic>stick figure</italic> and <italic>black sphere</italic>, respectively; <italic>C, enlarged view</italic> of the structure shown in Fig. 6<italic>B</italic>, looking from <italic>below</italic> on the 4-helix bundle of which Helix A is a member. The orientations of the side chains of Phe<sup>20</sup>, Thr<sup>21</sup>, Tyr<sup>23</sup>, Phe<sup>24</sup>, and Lys<sup>25</sup> amino acids in the Irga6 structure are shown.</p></caption><graphic xlink:href="zbc0480856330006"/></fig>
FIGURE 6.10D7 epitope is located in the Helix A of Irga6 protein.A, purified, nonmyristoylated recombinant Irga6wt, -Delta7-12, -Delta7-25, -Delta20-25, -F20A, -T21A, -G22A, -Y23A, -F24A, and -K25A proteins were subjected to SDS-PAGE and detected in Western blot with 10E7 and 10D7 antibodies. 10D7 signals were quantified, and values for mutants are given as percentages relative to the Irga6wt signal; B, crystal structure of Irga6 monomer (13), with Helix A, containing the 10D7 epitope, amino acids 20-25, indicated in red. The myristoyl group and the first 12 N-terminal amino acids have not yet been crystallographically resolved. GppNHp and Mg2+ are shown as an atomic stick figure and black sphere, respectively; C, enlarged view of the structure shown in Fig. 6B, looking from below on the 4-helix bundle of which Helix A is a member. The orientations of the side chains of Phe20, Thr21, Tyr23, Phe24, and Lys25 amino acids in the Irga6 structure are shown.
###end p 39
###begin p 40
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10D7 epitope is located in the Helix A of Irga6 protein.</bold>
###xml 56 57 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 395 396 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 434 436 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 514 517 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 641 643 629 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 667 679 655 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stick figure</italic>
###xml 684 696 672 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black sphere</italic>
###xml 712 728 700 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, enlarged view</italic>
###xml 761 762 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 777 782 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below</italic>
###xml 877 879 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">20</sup>
###xml 884 886 872 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">21</sup>
###xml 891 893 879 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink">23</sup>
###xml 898 900 886 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink">24</sup>
###xml 909 911 897 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">25</sup>
10D7 epitope is located in the Helix A of Irga6 protein.A, purified, nonmyristoylated recombinant Irga6wt, -Delta7-12, -Delta7-25, -Delta20-25, -F20A, -T21A, -G22A, -Y23A, -F24A, and -K25A proteins were subjected to SDS-PAGE and detected in Western blot with 10E7 and 10D7 antibodies. 10D7 signals were quantified, and values for mutants are given as percentages relative to the Irga6wt signal; B, crystal structure of Irga6 monomer (13), with Helix A, containing the 10D7 epitope, amino acids 20-25, indicated in red. The myristoyl group and the first 12 N-terminal amino acids have not yet been crystallographically resolved. GppNHp and Mg2+ are shown as an atomic stick figure and black sphere, respectively; C, enlarged view of the structure shown in Fig. 6B, looking from below on the 4-helix bundle of which Helix A is a member. The orientations of the side chains of Phe20, Thr21, Tyr23, Phe24, and Lys25 amino acids in the Irga6 structure are shown.
###end p 40
###begin p 41
###xml 332 338 328 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 629 631 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 699 700 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn8">6</xref>
###xml 985 987 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
The expression of the 10D7 epitope in full-length Irga6 was further investigated by transfection of wild-type and certain mutant constructs into uninduced L929 fibroblasts followed by immunoprecipitation of Irga6 with 10D7 antibody in the presence and absence of GTPgammaS added to the detergent lysate and subsequent Western blot (Fig. 7). As predicted from the properties of 10D7 summarized above, immunoprecipitation of wild-type Irga6 from the lysate was absolutely dependent on the presence of GTPgammaS. The functionally dominant negative mutant Irga6-K82A, which can bind GTP with wild-type affinity but not hydrolyze it (19), and a second mutation, Irga6-E106A, which has similar properties,6 were both immunoprecipitated by 10D7 whether GTPgammaS was added to the lysate or not, consistent with the expectation that these mutant proteins are already at least partially irreversibly GTP-bound at the time of lysis. Likewise, the nucleotide binding-deficient mutant Irga6-S83N (19) failed to bind significantly to 10D7 in absence or presence of GTPgammaS, consistent with the apparent GTP dependence of the epitope. Two mutants, however, failed to behave according to expectation in this assay. The mutant Irga6-Delta7-12 expressed the 10D7 epitope independently of GTPgammaS, whereas the mutant Irga6-G2A, which is mutated in the myristoyl attachment motif, failed to express the 10D7 epitope whether GTPgammaS was present or not. The behavior of these last two mutants suggested that expression of the 10D7 epitope is critically dependent on structural features at the N terminus that are not themselves part of the epitope and are also distant from the nucleotide binding site.
###end p 41
###begin p 42
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 9 121 9 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10D7 antibody binds to the GTP-bound form of native cellular Irga6 but not to a myristoylation-deficient mutant.</bold>
###xml 297 298 293 294 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 678 687 670 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">histogram</italic>
###xml 9 1039 9 1015 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><bold>10D7 antibody binds to the GTP-bound form of native cellular Irga6 but not to a myristoylation-deficient mutant.</bold> L929 fibroblasts were transfected with Irga6wt, -G2A, -&#916;7-12, -K82A, -S83N, or -E106A constructs. Cells were lysed 24 h later in Thesit in the absence or presence of 0.5 m<sc>m</sc> GTP&#947;S, and Irga6 was immunoprecipitated with 10D7-Protein A-Sepharose beads. Irga6 proteins were detected in Western blot by rabbit anti-Irga6 polyclonal 165 serum. Signals were quantified using ImageQuant TLv2005, and values for immunoprecipitated proteins were normalized to the corresponding lysates. Mean values of at least three independent experiments are shown in the <italic>histogram</italic>. The 10D7 epitope is dependent on GTP&#947;S in wild type Irga6 but constitutively expressed in functionally dominant negative mutants Irga6-K82A and -E106A. The myristoylation-deficient mutant, Irga6-G2A, cannot express the 10D7 epitope whether GTP&#947;S is present or not. The mutant Irga6-&#916;7-12 expresses 10D7 epitope independently of GTP&#947;S.</p>
###xml 9 1039 9 1015 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43"><bold>10D7 antibody binds to the GTP-bound form of native cellular Irga6 but not to a myristoylation-deficient mutant.</bold> L929 fibroblasts were transfected with Irga6wt, -G2A, -&#916;7-12, -K82A, -S83N, or -E106A constructs. Cells were lysed 24 h later in Thesit in the absence or presence of 0.5 m<sc>m</sc> GTP&#947;S, and Irga6 was immunoprecipitated with 10D7-Protein A-Sepharose beads. Irga6 proteins were detected in Western blot by rabbit anti-Irga6 polyclonal 165 serum. Signals were quantified using ImageQuant TLv2005, and values for immunoprecipitated proteins were normalized to the corresponding lysates. Mean values of at least three independent experiments are shown in the <italic>histogram</italic>. The 10D7 epitope is dependent on GTP&#947;S in wild type Irga6 but constitutively expressed in functionally dominant negative mutants Irga6-K82A and -E106A. The myristoylation-deficient mutant, Irga6-G2A, cannot express the 10D7 epitope whether GTP&#947;S is present or not. The mutant Irga6-&#916;7-12 expresses 10D7 epitope independently of GTP&#947;S.</p></caption>
###xml 1039 1039 1015 1015 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330007"/>
###xml 0 1039 0 1015 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="43"><bold>10D7 antibody binds to the GTP-bound form of native cellular Irga6 but not to a myristoylation-deficient mutant.</bold> L929 fibroblasts were transfected with Irga6wt, -G2A, -&#916;7-12, -K82A, -S83N, or -E106A constructs. Cells were lysed 24 h later in Thesit in the absence or presence of 0.5 m<sc>m</sc> GTP&#947;S, and Irga6 was immunoprecipitated with 10D7-Protein A-Sepharose beads. Irga6 proteins were detected in Western blot by rabbit anti-Irga6 polyclonal 165 serum. Signals were quantified using ImageQuant TLv2005, and values for immunoprecipitated proteins were normalized to the corresponding lysates. Mean values of at least three independent experiments are shown in the <italic>histogram</italic>. The 10D7 epitope is dependent on GTP&#947;S in wild type Irga6 but constitutively expressed in functionally dominant negative mutants Irga6-K82A and -E106A. The myristoylation-deficient mutant, Irga6-G2A, cannot express the 10D7 epitope whether GTP&#947;S is present or not. The mutant Irga6-&#916;7-12 expresses 10D7 epitope independently of GTP&#947;S.</p></caption><graphic xlink:href="zbc0480856330007"/></fig>
###xml 428 434 <span type="species:ncbi:9986">rabbit</span>
FIGURE 7.10D7 antibody binds to the GTP-bound form of native cellular Irga6 but not to a myristoylation-deficient mutant. L929 fibroblasts were transfected with Irga6wt, -G2A, -Delta7-12, -K82A, -S83N, or -E106A constructs. Cells were lysed 24 h later in Thesit in the absence or presence of 0.5 mm GTPgammaS, and Irga6 was immunoprecipitated with 10D7-Protein A-Sepharose beads. Irga6 proteins were detected in Western blot by rabbit anti-Irga6 polyclonal 165 serum. Signals were quantified using ImageQuant TLv2005, and values for immunoprecipitated proteins were normalized to the corresponding lysates. Mean values of at least three independent experiments are shown in the histogram. The 10D7 epitope is dependent on GTPgammaS in wild type Irga6 but constitutively expressed in functionally dominant negative mutants Irga6-K82A and -E106A. The myristoylation-deficient mutant, Irga6-G2A, cannot express the 10D7 epitope whether GTPgammaS is present or not. The mutant Irga6-Delta7-12 expresses 10D7 epitope independently of GTPgammaS.
###end p 42
###begin p 43
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10D7 antibody binds to the GTP-bound form of native cellular Irga6 but not to a myristoylation-deficient mutant.</bold>
###xml 288 289 284 285 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 669 678 661 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">histogram</italic>
###xml 419 425 <span type="species:ncbi:9986">rabbit</span>
10D7 antibody binds to the GTP-bound form of native cellular Irga6 but not to a myristoylation-deficient mutant. L929 fibroblasts were transfected with Irga6wt, -G2A, -Delta7-12, -K82A, -S83N, or -E106A constructs. Cells were lysed 24 h later in Thesit in the absence or presence of 0.5 mm GTPgammaS, and Irga6 was immunoprecipitated with 10D7-Protein A-Sepharose beads. Irga6 proteins were detected in Western blot by rabbit anti-Irga6 polyclonal 165 serum. Signals were quantified using ImageQuant TLv2005, and values for immunoprecipitated proteins were normalized to the corresponding lysates. Mean values of at least three independent experiments are shown in the histogram. The 10D7 epitope is dependent on GTPgammaS in wild type Irga6 but constitutively expressed in functionally dominant negative mutants Irga6-K82A and -E106A. The myristoylation-deficient mutant, Irga6-G2A, cannot express the 10D7 epitope whether GTPgammaS is present or not. The mutant Irga6-Delta7-12 expresses 10D7 epitope independently of GTPgammaS.
###end p 43
###begin p 44
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 8.</label>
###xml 9 122 9 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The myristoyl group, but not the proximal part of Helix A, is important for GTP-dependent Irga6 self-interaction.</bold>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 708 715 673 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 720 721 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 885 891 846 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 896 897 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 993 1000 954 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 1072 1079 1033 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 1086 1096 1047 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper band</italic>
###xml 1105 1109 1066 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane</italic>
###xml 1126 1141 1087 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">single asterisk</italic>
###xml 1220 1226 1181 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 9 1227 9 1188 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45"><bold>The myristoyl group, but not the proximal part of Helix A, is important for GTP-dependent Irga6 self-interaction.</bold> L929 fibroblasts were transfected with cTag1-tagged (<sup>**</sup>) and untagged (&#9656;) wild type and mutant Irga6 constructs. The mutants Irga6-G2A, -&#916;7-12, -K82A, -S83N, and -E106A were used. For each genotype, cells were transfected simultaneously with tagged and untagged constructs. Cells were lysed in Thesit 24 h later in the absence or presence of GTP&#947;S and immunoprecipitated with anti-cTag1 serum. Irga6 proteins were identified with 10D7 antibody in Western blot. Only the Irga6wt and Irga6-&#916;7-12 mutant showed typical GTP&#947;S-dependent co-precipitation (<italic>lanes 1</italic> and <italic>3</italic>, respectively). The two functionally dominant negative mutants, Irga6-K82A and -E106A, both co-precipitated untagged protein independently of exogenous GTP&#947;S (<italic>lane 4</italic> and <italic>6</italic>, respectively), whereas Irga6-G2A unexpectedly hardly co-precipitated untagged protein at all (<italic>lanes 2</italic>). Irga6cTag1-S83N showed no co-immunprecipitation of untagged protein (<italic>lanes 5</italic>). The <italic>upper band</italic> in each <italic>lane</italic>, labeled with a <italic>single asterisk</italic>, is the unexplained &#8220;transfection-specific&#8221; band referred to in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref>.</p>
###xml 9 1227 9 1188 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="45"><bold>The myristoyl group, but not the proximal part of Helix A, is important for GTP-dependent Irga6 self-interaction.</bold> L929 fibroblasts were transfected with cTag1-tagged (<sup>**</sup>) and untagged (&#9656;) wild type and mutant Irga6 constructs. The mutants Irga6-G2A, -&#916;7-12, -K82A, -S83N, and -E106A were used. For each genotype, cells were transfected simultaneously with tagged and untagged constructs. Cells were lysed in Thesit 24 h later in the absence or presence of GTP&#947;S and immunoprecipitated with anti-cTag1 serum. Irga6 proteins were identified with 10D7 antibody in Western blot. Only the Irga6wt and Irga6-&#916;7-12 mutant showed typical GTP&#947;S-dependent co-precipitation (<italic>lanes 1</italic> and <italic>3</italic>, respectively). The two functionally dominant negative mutants, Irga6-K82A and -E106A, both co-precipitated untagged protein independently of exogenous GTP&#947;S (<italic>lane 4</italic> and <italic>6</italic>, respectively), whereas Irga6-G2A unexpectedly hardly co-precipitated untagged protein at all (<italic>lanes 2</italic>). Irga6cTag1-S83N showed no co-immunprecipitation of untagged protein (<italic>lanes 5</italic>). The <italic>upper band</italic> in each <italic>lane</italic>, labeled with a <italic>single asterisk</italic>, is the unexplained &#8220;transfection-specific&#8221; band referred to in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref>.</p></caption>
###xml 1227 1227 1188 1188 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330008"/>
###xml 0 1227 0 1188 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>FIGURE 8.</label><caption><p textid="45"><bold>The myristoyl group, but not the proximal part of Helix A, is important for GTP-dependent Irga6 self-interaction.</bold> L929 fibroblasts were transfected with cTag1-tagged (<sup>**</sup>) and untagged (&#9656;) wild type and mutant Irga6 constructs. The mutants Irga6-G2A, -&#916;7-12, -K82A, -S83N, and -E106A were used. For each genotype, cells were transfected simultaneously with tagged and untagged constructs. Cells were lysed in Thesit 24 h later in the absence or presence of GTP&#947;S and immunoprecipitated with anti-cTag1 serum. Irga6 proteins were identified with 10D7 antibody in Western blot. Only the Irga6wt and Irga6-&#916;7-12 mutant showed typical GTP&#947;S-dependent co-precipitation (<italic>lanes 1</italic> and <italic>3</italic>, respectively). The two functionally dominant negative mutants, Irga6-K82A and -E106A, both co-precipitated untagged protein independently of exogenous GTP&#947;S (<italic>lane 4</italic> and <italic>6</italic>, respectively), whereas Irga6-G2A unexpectedly hardly co-precipitated untagged protein at all (<italic>lanes 2</italic>). Irga6cTag1-S83N showed no co-immunprecipitation of untagged protein (<italic>lanes 5</italic>). The <italic>upper band</italic> in each <italic>lane</italic>, labeled with a <italic>single asterisk</italic>, is the unexplained &#8220;transfection-specific&#8221; band referred to in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref>.</p></caption><graphic xlink:href="zbc0480856330008"/></fig>
FIGURE 8.The myristoyl group, but not the proximal part of Helix A, is important for GTP-dependent Irga6 self-interaction. L929 fibroblasts were transfected with cTag1-tagged (**) and untagged (black triangle right) wild type and mutant Irga6 constructs. The mutants Irga6-G2A, -Delta7-12, -K82A, -S83N, and -E106A were used. For each genotype, cells were transfected simultaneously with tagged and untagged constructs. Cells were lysed in Thesit 24 h later in the absence or presence of GTPgammaS and immunoprecipitated with anti-cTag1 serum. Irga6 proteins were identified with 10D7 antibody in Western blot. Only the Irga6wt and Irga6-Delta7-12 mutant showed typical GTPgammaS-dependent co-precipitation (lanes 1 and 3, respectively). The two functionally dominant negative mutants, Irga6-K82A and -E106A, both co-precipitated untagged protein independently of exogenous GTPgammaS (lane 4 and 6, respectively), whereas Irga6-G2A unexpectedly hardly co-precipitated untagged protein at all (lanes 2). Irga6cTag1-S83N showed no co-immunprecipitation of untagged protein (lanes 5). The upper band in each lane, labeled with a single asterisk, is the unexplained "transfection-specific" band referred to in the legend to Fig. 3.
###end p 44
###begin p 45
###xml 0 113 0 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The myristoyl group, but not the proximal part of Helix A, is important for GTP-dependent Irga6 self-interaction.</bold>
###xml 167 169 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 699 706 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 711 712 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 876 882 837 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 887 888 848 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 984 991 945 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 1063 1070 1024 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 1077 1087 1038 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper band</italic>
###xml 1096 1100 1057 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane</italic>
###xml 1117 1132 1078 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">single asterisk</italic>
###xml 1211 1217 1172 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
The myristoyl group, but not the proximal part of Helix A, is important for GTP-dependent Irga6 self-interaction. L929 fibroblasts were transfected with cTag1-tagged (**) and untagged (black triangle right) wild type and mutant Irga6 constructs. The mutants Irga6-G2A, -Delta7-12, -K82A, -S83N, and -E106A were used. For each genotype, cells were transfected simultaneously with tagged and untagged constructs. Cells were lysed in Thesit 24 h later in the absence or presence of GTPgammaS and immunoprecipitated with anti-cTag1 serum. Irga6 proteins were identified with 10D7 antibody in Western blot. Only the Irga6wt and Irga6-Delta7-12 mutant showed typical GTPgammaS-dependent co-precipitation (lanes 1 and 3, respectively). The two functionally dominant negative mutants, Irga6-K82A and -E106A, both co-precipitated untagged protein independently of exogenous GTPgammaS (lane 4 and 6, respectively), whereas Irga6-G2A unexpectedly hardly co-precipitated untagged protein at all (lanes 2). Irga6cTag1-S83N showed no co-immunprecipitation of untagged protein (lanes 5). The upper band in each lane, labeled with a single asterisk, is the unexplained "transfection-specific" band referred to in the legend to Fig. 3.
###end p 45
###begin p 46
###xml 462 468 446 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 470 477 454 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 522 529 506 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 837 844 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 849 850 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 1158 1165 1134 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 1323 1330 1295 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
The apparently constitutive expression of the 10D7 epitope on the N-terminal deletion mutant, Irga6-Delta7-12, could suggest that this mutant, for unknown reasons, behaves like Irga6-K82A as a dominant negative, being constitutively GTP-bound in transfected cells. We investigated this possibility by co-immunoprecipitation from uninduced cells of transfected, untagged Irga6-Delta7-12 with transfected Irga6cTag1-Delta7-12. By this assay, Irga6cTag1-Delta7-12 (Fig. 8, lanes 3) behaved exactly like wild-type Irga6cTag1 (lanes 1), showing complete GTPgammaS dependence for co-precipitation of the untagged protein and thus suggesting that the nucleotide-binding site of this mutant is not irreversibly occupied by GTP. In contrast, in the same assay, the two functionally dominant negative mutants Irga6cTag1-K82A and Irga6cTag1-E106A (lanes 4 and 6, respectively) co-precipitated their untagged equivalents weakly but constitutively, independently of GTPgammaS, consistent with the expectation that these proteins were already partially in irreversible GTP-dependent aggregates before cell lysis, whereas the GTP binding-deficient mutant, Irga6cTag1-S83N (lanes 5), as expected, failed to co-immunoprecipitate the untagged mutant whether GTPgammaS was present or not. The myristoylation-deficient mutant, Irga6cTag1-G2A (lanes 2) showed very weak GTPgammaS-dependent co-precipitation of the untagged mutant, confirming that absence of the myristoyl group has seriously disturbed, if not completely destroyed, the normal conformational behavior of the mutant.
###end p 46
###begin p 47
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
In aggregate, the data strongly suggest that complex conformational changes occur in Irga6 as a consequence of GTP binding. The 10D7 epitope is exposed by GTP binding although itself distant from the nucleotide binding site. Since the epitope is partially buried in the known crystal structures of Irga6 (13) and looks inaccessible to antibody, it is likely that GTP binding results in restructuring of the Helix A, exposing the whole linear epitope probably with partial unfolding. Indeed, the 10D7 epitope is probably loosely structured, since it is well expressed on Western blots of any Irga6 protein or fragment that contains the intact 20-25 sequence of Helix A. This property is also consistent with the fact that the 10D7 monoclonal antibody was produced in mice immunized with bacterially expressed Irga6 in Freund's complete adjuvant; the protein was probably largely denatured. In material isolated from cells, which is not intentionally denatured, the 10D7 epitope is constitutively exposed by loss of residues 7-12, which were not resolved in known crystal structures, suggesting that the presence of these residues is required to maintain Helix A in the "closed" configuration in the absence of GTP. Likewise, loss of the myristoyl moiety results in constitutive loss of the 10D7 epitope in material isolated from cells, hinting that a direct or indirect interaction between the myristoyl group and Helix A is required to enable the GTP-dependent conformational change in Helix A to occur in otherwise normally conformed molecules.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 193 202 193 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 663 672 659 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 707 713 703 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 734 742 730 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 882 884 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 1062 1068 1058 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1351 1353 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1622 1628 1618 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 193 202 <span type="species:ncbi:5811">T. gondii</span>
###xml 663 672 <span type="species:ncbi:5811">T. gondii</span>
In this study, we have provided evidence that Irga6 in interferon-induced cells must be predominantly GDP-bound (or possibly empty of nucleotide), whereas Irga6 that accumulates rapidly on the T. gondii parasitophorous vacuole in such cells is in the GTP-bound state. There are several grounds for believing that this change of state is accompanied by a significant conformational change in the Irga6 molecule. First, we present evidence that the target epitope of the anti-Irga6 monoclonal antibody, 10D7, is exposed on native wild-type Irga6 only when GTP, GTPgammaS, or GDP-AlFx is bound, and we show that it is strongly expressed on Irga6 associated with the T. gondii parasitophorous vacuole membrane (Fig. 1). Second, published in vitro experiments have shown that soluble monomeric Irga6 forms oligomers in the presence of GTP that can be stabilized by the presence of AlFx (16), showing that new interfaces are formed as a result of GTP binding and formation of the catalytic transition state that allow high affinity interaction between Irga6 monomers (Fig. 3). Finally, the binding of 10D7 to Irga6 molecules is influenced by at least two other elements of the protein for which unfortunately no structural information yet exists, namely amino acids 7-12 adjacent to the N terminus, which are not resolved in any crystal structure of Irga6 (13), and the myristoyl group, which was not present on the bacterially expressed protein from which the crystal structures were obtained. The individual absence of these two elements resulted in constitutive gain and constitutive loss, respectively, of the 10D7 epitope (Fig. 7).
###end p 49
###begin p 50
###xml 219 220 218 219 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 220 226 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 232 233 230 231 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 303 305 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 416 417 413 414 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 417 423 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 430 431 426 427 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 434 436 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 591 593 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1114 1116 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 1266 1268 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1270 1272 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1546 1548 1542 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1645 1647 1641 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1722 1724 1718 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1857 1859 1853 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1953 1955 1937 1939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 2605 2607 2585 2587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
On kinetic grounds, we should expect that cytoplasmic Irga6 will be predominantly in the GDP-bound form. The single-site equilibrium affinity constant of bacterially purified Irga6 for GDP is 15 times that for GTP (1 mumversus 15 mum) a difference accounted for entirely by the difference in off-rates (16), whereas the concentration of free cellular GTP is reported to be only 3-fold higher than that of GDP (330 mumversus 129 mum) (27). In addition, it is likely that the conformational change associated with GTP binding requires at least a dimerization of two GTP-bound Irga6 molecules (13), whereas the level of GTP-bound molecules will depend on the balance between the growth of GTP-bound, activated oligomers and their loss through hydrolysis of the bound GTP. Not all of the parameters required to calculate the expected level of GTP-bound, activated, oligomeric Irga6 are available, but it is clear that activated oligomers are expected to be rare relative to monomeric GDP-bound Irga6 or, presumably, nonactivated, monomeric Irga6 molecules, with GTP bound transiently to the low affinity binding site (16). Nevertheless, when Irga6 is expressed alone in uninduced cells, the protein accumulates in the GTP-bound state in aggregates of unknown structure (15, 19). We have shown that this transition is prevented in interferon-induced cells by direct interactions between Irga6 and three other members of the IRG family, the GMS proteins Irgm1, Irgm2, and Irgm3, with their distinctive G1 motif sequence in the nucleotide-binding site (19). In the case of Irgm3, we could also show that GDP is required for the interaction with Irga6 (19). Since the GMS proteins are predominantly or exclusively membrane-bound (15), we have argued that effective interactions between Irga6 and GMS proteins occur on cellular membranes rather than in the cytosol (19). Irga6 is approximately60% bound to the ER membrane and 40% cytosolic in IFN-induced cells (15), presumably in a dynamic equilibrium, and it is plausible that the much higher effective concentration of Irga6 on ER membranes than in the cytosol tends to increase the rate of formation of activated GTP-bound dimers and oligomers in the transiently membrane-bound pool. Our speculation on the role of the GMS proteins is that they attenuate the activation process at intracellular membranes by retaining Irga6 molecules in the GDP-bound state until they are released from the membrane. In the absence of GMS proteins, in cells not stimulated with IFNgamma and expressing Irga6 by transfection or by induction from a synthetic inducible promoter (19), activation of Irga6 proceeds until the rate of GTP hydrolysis is equal to the rate of growth of activated oligomers, resulting in a steady state with visible GTP-bound Irga6 accumulations with a high affinity for 10D7.
###end p 50
###begin p 51
###xml 283 292 283 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn9">7</xref>
###xml 790 811 790 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chlamydia trachomatis</italic>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 859 871 859 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sine qua non</italic>
###xml 1054 1056 1054 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1433 1435 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 1436 1438 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 283 292 <span type="species:ncbi:5811">T. gondii</span>
###xml 551 554 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
###xml 746 751 <span type="species:ncbi:10090">mouse</span>
###xml 790 811 <span type="species:ncbi:813">Chlamydia trachomatis</span>
The role of the myristoyl group in the conformational transition associated with GTP-dependent activation of Irga6 and exposure of the 10D7 epitope is unclear. We have shown that the nonmyristoylated Irga6-G2A mutant can transfer only inefficiently to the parasitophorous vacuole in T. gondii-infected IFN-induced cells and also acts as a weak dominant negative, reducing the efficiency with which wild-type Irga6 accumulates on the vacuole.7 This suggests that the myristoyl group is required for strong association of the activated protein with the PVM and is likely to be essential for the resistance function. A similar conjecture was made recently for the presumed myristoylation of another IRG protein, Irgb10, in its role in resistance of mouse cells against the vacuolar bacterium, Chlamydia trachomatis (28). Nevertheless, myristoylation cannot be a sine qua non of effector function in all IRG proteins, since several other members of the family do not carry a myristoylation signal, including all three GMS proteins as well as Irgb6 and Irgd (14). A GTP-dependent exposure of the myristoyl group associated with protein function at membranes is reminiscent of the properties of another myristoylated GTPase, ARF1, where the myristoyl group, normally partially buried in the protein structure, is exposed by a conformational change initiated by binding of GTP and contributes to the docking of ARF1 to its target membrane (29-31).
###end p 51
###begin p 52
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 3 10 3 10 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9<italic>A</italic></xref>
###xml 521 530 521 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T. gondii</italic>
###xml 675 676 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 669 676 669 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9<italic>B</italic></xref>
###xml 903 905 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 1131 1132 1131 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 1134 1135 1134 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 521 530 <span type="species:ncbi:5811">T. gondii</span>
###xml 531 534 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
In Fig. 9A, we present a preliminary model for the conformational effects we have documented, based on the hypothesis that the 10D7 determinant is generated by a conformational transition in Helix A from a helical to an extended conformation, a transition that normally occurs when GTP-bound Irga6 monomers interact to form a dimer (or possibly higher order oligomer) and in which repositioning of the myristoyl group plays a role. We further hypothesize that such dimers or higher order oligomers, when assembled on the T. gondii PVM, represent the active form of the IRG protein, a form in which it is equipped to exercise its effector function against the parasite (Fig. 9B). By analogy with another large GTPase, dynamin, which associates with its target membranes at the neck of clathrin-coated endocytic invaginations in the GTP-bound state and functions in vesicle scission by hydrolysis of GTP (32, 33), it is plausible that the effector function of Irga6 and other IRG proteins of the GKS group is fulfilled via GTP hydrolysis at the parasitophorous vacuole membrane, leading to the observed vesiculation of the membrane (6, 8) and ultimately to its rupture.
###end p 52
###begin p 53
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 9.</label>
###xml 9 92 9 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Model of Irga6 nucleotide-dependent conformational change and membrane interaction.</bold>
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 256 269 256 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow strand</italic>
###xml 306 309 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 430 440 430 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green oval</italic>
###xml 974 981 970 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1035 1036 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 1594 9 1586 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54"><bold>Model of Irga6 nucleotide-dependent conformational change and membrane interaction.</bold><italic>A</italic>, the model proposes that regulated GTP binding by wild-type Irga6 initiates a complex conformational change requiring the presence of a &#8220;hinge&#8221; at residues 7-12 (<italic>yellow strand</italic>) that releases the myristoyl group (<italic>red</italic>) from a bound or cryptic configuration and exposes the 10D7 determinant by partial unfolding of Helix A residues 20-25 (<italic>green oval</italic>). In the absence of the myristoyl group (G2A), the motion is aborted for unknown reasons, and the 10D7 epitope is not exposed. In the &#916;7-12 mutant, the critical hinge-like residues are absent, the myristoyl group is constitutively mispositioned, and the 10D7 epitope is constitutively exposed. In the S83N mutant, which cannot bind nucleotides, Irga6 is constitutively in the inactive, closed configuration, and the 10D7 determinant is constitutively not exposed. In the K82A and E106A mutants, Irga6 is constitutively GTP-bound <italic>in vivo</italic>, and the 10D7 determinant is constitutively exposed. <italic>B</italic>, in IFN&#947;-induced cells, the GMS group of 3 IRG proteins favor the GDP-bound inactive state of Irga6, which remains predominantly monomeric in the cytoplasm and at the ER membrane with the 10D7 epitope not exposed. Upon infection, Irga6 is released by an unknown mechanism from GMS control and interacts with the PVM in its GTP-bound form, probably by insertion of the myristoyl group, and exposing the 10D7 epitope. Homooligomerization of GTP-bound Irga6 could increase the avidity of this interaction, stabilizing active Irga6 on the vacuolar membrane.</p>
###xml 9 1594 9 1586 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="54"><bold>Model of Irga6 nucleotide-dependent conformational change and membrane interaction.</bold><italic>A</italic>, the model proposes that regulated GTP binding by wild-type Irga6 initiates a complex conformational change requiring the presence of a &#8220;hinge&#8221; at residues 7-12 (<italic>yellow strand</italic>) that releases the myristoyl group (<italic>red</italic>) from a bound or cryptic configuration and exposes the 10D7 determinant by partial unfolding of Helix A residues 20-25 (<italic>green oval</italic>). In the absence of the myristoyl group (G2A), the motion is aborted for unknown reasons, and the 10D7 epitope is not exposed. In the &#916;7-12 mutant, the critical hinge-like residues are absent, the myristoyl group is constitutively mispositioned, and the 10D7 epitope is constitutively exposed. In the S83N mutant, which cannot bind nucleotides, Irga6 is constitutively in the inactive, closed configuration, and the 10D7 determinant is constitutively not exposed. In the K82A and E106A mutants, Irga6 is constitutively GTP-bound <italic>in vivo</italic>, and the 10D7 determinant is constitutively exposed. <italic>B</italic>, in IFN&#947;-induced cells, the GMS group of 3 IRG proteins favor the GDP-bound inactive state of Irga6, which remains predominantly monomeric in the cytoplasm and at the ER membrane with the 10D7 epitope not exposed. Upon infection, Irga6 is released by an unknown mechanism from GMS control and interacts with the PVM in its GTP-bound form, probably by insertion of the myristoyl group, and exposing the 10D7 epitope. Homooligomerization of GTP-bound Irga6 could increase the avidity of this interaction, stabilizing active Irga6 on the vacuolar membrane.</p></caption>
###xml 1594 1594 1586 1586 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0480856330009"/>
###xml 0 1594 0 1586 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig9"><label>FIGURE 9.</label><caption><p textid="54"><bold>Model of Irga6 nucleotide-dependent conformational change and membrane interaction.</bold><italic>A</italic>, the model proposes that regulated GTP binding by wild-type Irga6 initiates a complex conformational change requiring the presence of a &#8220;hinge&#8221; at residues 7-12 (<italic>yellow strand</italic>) that releases the myristoyl group (<italic>red</italic>) from a bound or cryptic configuration and exposes the 10D7 determinant by partial unfolding of Helix A residues 20-25 (<italic>green oval</italic>). In the absence of the myristoyl group (G2A), the motion is aborted for unknown reasons, and the 10D7 epitope is not exposed. In the &#916;7-12 mutant, the critical hinge-like residues are absent, the myristoyl group is constitutively mispositioned, and the 10D7 epitope is constitutively exposed. In the S83N mutant, which cannot bind nucleotides, Irga6 is constitutively in the inactive, closed configuration, and the 10D7 determinant is constitutively not exposed. In the K82A and E106A mutants, Irga6 is constitutively GTP-bound <italic>in vivo</italic>, and the 10D7 determinant is constitutively exposed. <italic>B</italic>, in IFN&#947;-induced cells, the GMS group of 3 IRG proteins favor the GDP-bound inactive state of Irga6, which remains predominantly monomeric in the cytoplasm and at the ER membrane with the 10D7 epitope not exposed. Upon infection, Irga6 is released by an unknown mechanism from GMS control and interacts with the PVM in its GTP-bound form, probably by insertion of the myristoyl group, and exposing the 10D7 epitope. Homooligomerization of GTP-bound Irga6 could increase the avidity of this interaction, stabilizing active Irga6 on the vacuolar membrane.</p></caption><graphic xlink:href="zbc0480856330009"/></fig>
###xml 1353 1356 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
FIGURE 9.Model of Irga6 nucleotide-dependent conformational change and membrane interaction.A, the model proposes that regulated GTP binding by wild-type Irga6 initiates a complex conformational change requiring the presence of a "hinge" at residues 7-12 (yellow strand) that releases the myristoyl group (red) from a bound or cryptic configuration and exposes the 10D7 determinant by partial unfolding of Helix A residues 20-25 (green oval). In the absence of the myristoyl group (G2A), the motion is aborted for unknown reasons, and the 10D7 epitope is not exposed. In the Delta7-12 mutant, the critical hinge-like residues are absent, the myristoyl group is constitutively mispositioned, and the 10D7 epitope is constitutively exposed. In the S83N mutant, which cannot bind nucleotides, Irga6 is constitutively in the inactive, closed configuration, and the 10D7 determinant is constitutively not exposed. In the K82A and E106A mutants, Irga6 is constitutively GTP-bound in vivo, and the 10D7 determinant is constitutively exposed. B, in IFNgamma-induced cells, the GMS group of 3 IRG proteins favor the GDP-bound inactive state of Irga6, which remains predominantly monomeric in the cytoplasm and at the ER membrane with the 10D7 epitope not exposed. Upon infection, Irga6 is released by an unknown mechanism from GMS control and interacts with the PVM in its GTP-bound form, probably by insertion of the myristoyl group, and exposing the 10D7 epitope. Homooligomerization of GTP-bound Irga6 could increase the avidity of this interaction, stabilizing active Irga6 on the vacuolar membrane.
###end p 53
###begin p 54
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Model of Irga6 nucleotide-dependent conformational change and membrane interaction.</bold>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 247 260 247 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow strand</italic>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 421 431 421 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green oval</italic>
###xml 965 972 961 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1026 1027 1022 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1344 1347 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
Model of Irga6 nucleotide-dependent conformational change and membrane interaction.A, the model proposes that regulated GTP binding by wild-type Irga6 initiates a complex conformational change requiring the presence of a "hinge" at residues 7-12 (yellow strand) that releases the myristoyl group (red) from a bound or cryptic configuration and exposes the 10D7 determinant by partial unfolding of Helix A residues 20-25 (green oval). In the absence of the myristoyl group (G2A), the motion is aborted for unknown reasons, and the 10D7 epitope is not exposed. In the Delta7-12 mutant, the critical hinge-like residues are absent, the myristoyl group is constitutively mispositioned, and the 10D7 epitope is constitutively exposed. In the S83N mutant, which cannot bind nucleotides, Irga6 is constitutively in the inactive, closed configuration, and the 10D7 determinant is constitutively not exposed. In the K82A and E106A mutants, Irga6 is constitutively GTP-bound in vivo, and the 10D7 determinant is constitutively exposed. B, in IFNgamma-induced cells, the GMS group of 3 IRG proteins favor the GDP-bound inactive state of Irga6, which remains predominantly monomeric in the cytoplasm and at the ER membrane with the 10D7 epitope not exposed. Upon infection, Irga6 is released by an unknown mechanism from GMS control and interacts with the PVM in its GTP-bound form, probably by insertion of the myristoyl group, and exposing the 10D7 epitope. Homooligomerization of GTP-bound Irga6 could increase the avidity of this interaction, stabilizing active Irga6 on the vacuolar membrane.
###end p 54
###begin title 55
Supplementary Material
###end title 55
###begin title 56
[Supplemental Data]
###end title 56
###begin p 57
We are grateful to Rita Lange, Manuel von Osten, and Claudia Poschner for assistance at various points during this study and to members of the laboratory for valuable discussions.
###end p 57
###begin p 58
###xml 161 162 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 182 185 <span type="species:ncbi:11263?0.47540983606557374|species:ncbi:12167?0.09016393442622951">PVM</span>
The abbreviations used are: IRG, immunity-related GTPase; IMDM, Iscove's modified Dulbecco's medium; AlFx, aluminum fluoride complex; GTPgammaS, guanosine 5'-(3-O-thio)triphosphate; PVM, parasitophorous vacuole membrane; IFNgamma, interferon gamma; PBS, phosphate-buffered saline; ER, endoplasmic reticulum.
###end p 58
###begin p 59
A. Khaminets, unpublished data.
###end p 59
###begin p 60
R. Uthaiah, unpublished results.
###end p 60
###begin p 61
N. Pawlowski, unpublished data.
###end p 61
###begin p 62
N. Papic, unpublished data.
###end p 62

